{"meta":{"query_hash":"236721995b72","filters":{"venue":"OncoTargets and Therapy"},"cohort_total":79,"direct_labels_cover":0,"predictions_cover":79,"exported":79,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/236721995b72","api":"https://metacan.xera.ac/api/v1/cohort?venue=OncoTargets+and+Therapy"},"results":[{"id":"W1702959498","doi":"10.2147/ott.s85130","title":"CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies","year":2015,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Government of Jiangsu Province; Natural Science Foundation of Jiangsu Province; National Natural Science Foundation of China","keywords":"Medicine; Breast cancer; Androgen receptor; Odds ratio; Meta-analysis; Oncology; Internal medicine; Allele; Confidence interval; Subgroup analysis; Publication bias; Case-control study; Population; Cancer; Gynecology; Bioinformatics; Genetics; Prostate cancer; Gene; Biology","score_opus":0.08916752688260887,"score_gpt":0.3731327522712774,"score_spread":0.28396522538866853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1702959498","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023890685,0.9752282,7.686404e-7,0.000084452695,0.000034957935,0.00029064843,0.00042752663,0.0000017827614,0.000040992592],"genre_scores_gemma":[0.00337047,0.9957944,0.000009397656,0.00023545854,0.000029787565,0.00020993274,0.00017815715,0.0000146405055,0.00015772259],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865854,0.0003321079,0.00036417742,0.00035614724,0.00012333845,0.00016566318],"domain_scores_gemma":[0.9993416,0.000035685996,0.00026033755,0.00026516622,0.000050934326,0.00004626274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005153685,0.00025854816,0.001529864,0.00016834153,0.000032752294,0.000017119168,0.00012415969,0.00014971916,0.000085826854],"category_scores_gemma":[0.000016455053,0.00013958778,0.00031107216,0.00031095048,0.00008881341,0.0000033888496,0.000043235872,0.00010039072,2.74583e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026973023,0.0004071052,0.0041343034,0.0005471725,0.13744657,0.0000039782326,0.005206827,0.000010363969,0.000054597713,0.000027272283,0.0026807033,0.8492114],"study_design_scores_gemma":[0.00077317515,0.00016959352,0.00093028543,0.000054515232,0.015099693,0.0000041625835,0.00086808484,0.0000033854467,0.000006050704,0.000058669095,0.98172814,0.00030422275],"about_ca_topic_score_codex":0.00031309627,"about_ca_topic_score_gemma":0.00055697834,"teacher_disagreement_score":0.9790475,"about_ca_system_score_codex":0.000020382155,"about_ca_system_score_gemma":0.00006907365,"threshold_uncertainty_score":0.5692224},"labels":[],"label_agreement":null},{"id":"W1740131825","doi":"10.2147/ott.s84034","title":"Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjects","year":2015,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Meta-analysis; Medicine; Odds ratio; Subgroup analysis; Confidence interval; Prostate cancer; Internal medicine; Oncology; Cancer","score_opus":0.16089995007452496,"score_gpt":0.37259697487077964,"score_spread":0.21169702479625468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1740131825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7328426,0.26300585,0.0000020738532,0.003367316,0.000055713677,0.00044530837,0.00017184071,0.000021830392,0.000087429595],"genre_scores_gemma":[0.91186744,0.08585111,0.0002702449,0.0005064013,0.00009361468,0.0001526421,0.00008057815,0.00002270057,0.0011552653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835837,0.00010963754,0.00041439402,0.00043684154,0.00038916836,0.00029158176],"domain_scores_gemma":[0.99853367,0.00023122244,0.00034672205,0.00026875793,0.00040449292,0.00021515069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000736571,0.00026661868,0.0015479908,0.00019172262,0.00009374275,0.00003253257,0.00004355004,0.00009019644,0.00010153321],"category_scores_gemma":[0.00008449725,0.00017668404,0.0003217167,0.00038329663,0.00010212358,0.00012360122,0.00004495825,0.000107500055,0.0000011655725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000160345,0.00017340382,0.8511802,0.000047525948,0.13573605,0.0000059049166,0.005533008,0.0000061436754,0.00062787853,0.00002220087,0.001526804,0.0049805436],"study_design_scores_gemma":[0.008309765,0.002032506,0.74946785,0.000098779245,0.20555334,0.000002918894,0.0012202525,0.000052693475,0.005644534,0.0015767586,0.02543465,0.0006059427],"about_ca_topic_score_codex":0.0013685701,"about_ca_topic_score_gemma":0.0012754477,"teacher_disagreement_score":0.1790248,"about_ca_system_score_codex":0.00028555773,"about_ca_system_score_gemma":0.00011891175,"threshold_uncertainty_score":0.7204966},"labels":[],"label_agreement":null},{"id":"W1781552324","doi":"10.2147/ott.s90875","title":"Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients","year":2015,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Hazard ratio; Internal medicine; Confidence interval; Neutrophil to lymphocyte ratio; Meta-analysis; Oncology; Cochrane Library; Lymphocyte; Gastroenterology","score_opus":0.07185449878803782,"score_gpt":0.3266945549584599,"score_spread":0.25484005617042205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1781552324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786169,0.01932205,0.000039714898,0.00031258044,0.00007029268,0.00089443696,0.000036146288,0.000027887245,0.0006800275],"genre_scores_gemma":[0.99727845,0.000387824,0.0014519657,0.00048749128,0.000056172463,0.00020340386,0.000043273958,0.000027638258,0.00006375676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983281,0.000112481386,0.00046355982,0.00037644277,0.00042728396,0.00029213759],"domain_scores_gemma":[0.9988127,0.00006656773,0.00017261032,0.00032992437,0.00029060704,0.0003275917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041002146,0.00023624588,0.00090119574,0.00038473142,0.000055923036,0.000026428017,0.000111433845,0.00007973517,0.00012855006],"category_scores_gemma":[0.00010922278,0.00017852422,0.00035400444,0.00068793,0.000058797563,0.00011500123,0.000065680404,0.000075809425,0.0000053054982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014765193,0.00035287972,0.96666396,0.000055053104,0.023524024,0.000014236379,0.002238813,0.000167615,0.0012366577,0.000041876403,0.00036166806,0.003866728],"study_design_scores_gemma":[0.014066391,0.0013291959,0.8774068,0.00010413164,0.06207034,0.0000062885024,0.00061694917,0.004040055,0.0058904267,0.0005849027,0.032904483,0.0009800557],"about_ca_topic_score_codex":0.0004180754,"about_ca_topic_score_gemma":0.000122001606,"teacher_disagreement_score":0.08925715,"about_ca_system_score_codex":0.00029442983,"about_ca_system_score_gemma":0.0002725821,"threshold_uncertainty_score":0.72800064},"labels":[],"label_agreement":null},{"id":"W1966461118","doi":"10.2147/ott.s72974","title":"Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lymph node; Mediastinal lymph node; Radiology; Endobronchial ultrasound; Lung cancer; Lymph; Mediastinal lymphadenopathy; Pathology; Biopsy; Cancer; Metastasis; Internal medicine","score_opus":0.06298299379743237,"score_gpt":0.36544294807560934,"score_spread":0.30245995427817696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966461118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97515637,0.021164175,0.0023020233,0.0006933358,0.000042515145,0.00040951013,0.000018374678,0.000012833127,0.00020087566],"genre_scores_gemma":[0.98655665,0.0112364935,0.0016223901,0.00039051697,0.00004111193,0.000104480714,0.000022365339,0.000013680002,0.000012311816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994567,0.00001977543,0.00013396791,0.0001851786,0.00009708613,0.000107287335],"domain_scores_gemma":[0.999582,0.00011558948,0.00006109921,0.00012003557,0.00005342997,0.000067831745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098179815,0.000102364844,0.00025267986,0.000047986603,0.000048614656,0.000010802425,0.000018608747,0.00003473916,0.000027449423],"category_scores_gemma":[0.000021923843,0.0000696041,0.000060967755,0.000055323027,0.00004616069,0.000011089757,0.000007680886,0.000019165958,2.2399519e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053826533,0.0014614734,0.5842209,0.00036715934,0.00083202304,0.0000053463154,0.0008613808,0.00016680123,0.012344623,0.0048404858,0.000969549,0.393392],"study_design_scores_gemma":[0.014288804,0.0053946925,0.60383636,0.00047916992,0.0007150958,0.000010885314,0.00014749014,0.0101978425,0.25851884,0.0019624468,0.10402337,0.00042503324],"about_ca_topic_score_codex":0.00009218798,"about_ca_topic_score_gemma":0.0000080651,"teacher_disagreement_score":0.39296696,"about_ca_system_score_codex":0.000017154762,"about_ca_system_score_gemma":0.000016283084,"threshold_uncertainty_score":0.2838373},"labels":[],"label_agreement":null},{"id":"W1987367854","doi":"10.2147/ott.s30373","title":"Profile of erlotinib and its potential in the treatment of advanced ovarian carcinoma","year":2013,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Erlotinib; Ovarian carcinoma; Medicine; Oncology; Carcinoma; Internal medicine; Ovarian cancer; Cancer research; Cancer; Epidermal growth factor receptor","score_opus":0.015431443605721327,"score_gpt":0.2651156672300822,"score_spread":0.24968422362436085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987367854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98056406,0.016175894,9.130329e-7,0.0015233879,0.000045997745,0.0009865214,0.000014249623,0.0000037188952,0.000685271],"genre_scores_gemma":[0.98854494,0.010739425,0.0003084181,0.00009522595,0.000044998236,0.00015237331,0.000008260664,0.000008788394,0.00009757965],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994299,0.000029480883,0.00017457001,0.00015111802,0.000097759665,0.000117192096],"domain_scores_gemma":[0.99967617,0.000034087763,0.00006795879,0.00013615267,0.000041756914,0.000043848035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047770944,0.00010837345,0.00027214186,0.00004057644,0.000025344645,0.0000066627726,0.000027281374,0.00003552171,0.00018387094],"category_scores_gemma":[0.0000019824267,0.00005792642,0.000045306235,0.00006307792,0.000037615762,0.000041578067,0.0000044435883,0.000028219114,0.0000015207772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009957522,0.0049624797,0.380622,0.00012299133,0.00036961256,0.00006300272,0.009066525,0.0000045300785,0.022767458,0.0019105371,0.00020565717,0.57890946],"study_design_scores_gemma":[0.00826445,0.0040313257,0.9703493,0.00003935044,0.000039784678,0.000013018507,0.0003215411,0.000100051286,0.01285811,0.00019181345,0.0037251837,0.000066075205],"about_ca_topic_score_codex":0.0004934678,"about_ca_topic_score_gemma":0.000016487007,"teacher_disagreement_score":0.5897273,"about_ca_system_score_codex":0.000017794533,"about_ca_system_score_gemma":0.00003058947,"threshold_uncertainty_score":0.23621708},"labels":[],"label_agreement":null},{"id":"W2016406604","doi":"10.2147/ott.s53348","title":"Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes","year":2013,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Incyte","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Extramedullary hematopoiesis; Pharmacology; Intensive care medicine; Internal medicine; Oncology; Bone marrow; Haematopoiesis","score_opus":0.00958283741905231,"score_gpt":0.25374510316316334,"score_spread":0.24416226574411104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016406604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968984,0.00021100276,0.000001457702,0.00023799506,0.0000054993225,0.0016862284,0.000015410458,0.000008610789,0.00093537214],"genre_scores_gemma":[0.99846643,0.0006323621,0.0005004311,0.000048080972,0.0000033538709,0.0002059464,0.00003012072,0.000015863001,0.0000974343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992404,0.000042441705,0.0001955404,0.0002202952,0.00016915005,0.00013219449],"domain_scores_gemma":[0.9994571,0.00012266183,0.00009503529,0.0001879057,0.00006350545,0.00007375162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053930904,0.0001838293,0.00045935236,0.000088138986,0.00003454865,0.000010063396,0.000027590622,0.000033034594,0.000047728652],"category_scores_gemma":[0.0000031068946,0.000091132555,0.000029173061,0.000106665604,0.00007462331,0.0000472585,0.000009500469,0.000046355304,0.0000021275778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019825855,0.0012335412,0.9636009,0.000068347916,0.00034194518,0.0000045676347,0.0002113975,0.0000035385583,0.00006853421,0.0003252423,0.000010267298,0.032149132],"study_design_scores_gemma":[0.018287841,0.0076616164,0.969002,0.00028584673,0.000071901595,6.4839617e-7,0.000025910365,0.000010073675,0.004488381,0.000010296965,0.000067805595,0.0000876633],"about_ca_topic_score_codex":0.0001435305,"about_ca_topic_score_gemma":0.0000049708397,"teacher_disagreement_score":0.03206147,"about_ca_system_score_codex":0.000018478015,"about_ca_system_score_gemma":0.000007941124,"threshold_uncertainty_score":0.37162778},"labels":[],"label_agreement":null},{"id":"W2026240866","doi":"10.2147/ott.s55344","title":"Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Sialidase; Pancreatic cancer; Cancer; Medicine; Cancer research; Oncology; Internal medicine; Virology; Neuraminidase; Virus","score_opus":0.012952168741766575,"score_gpt":0.2825901730194355,"score_spread":0.26963800427766893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026240866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96820426,0.030593285,0.000108149856,0.00007823254,0.000033954355,0.00033055266,0.000051865285,0.000009685968,0.0005900191],"genre_scores_gemma":[0.982888,0.01587052,0.00019256241,0.00010634845,0.00010744315,0.00018021988,0.0000838056,0.000049240334,0.000521875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998603,0.00009795282,0.00021045946,0.00044745716,0.00022222789,0.0004188977],"domain_scores_gemma":[0.99934566,0.000025073667,0.00014437507,0.0002882168,0.000083366365,0.00011328013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016989229,0.00027659666,0.00036523194,0.000029885225,0.00012246978,0.00003649713,0.00014756707,0.00007426664,0.00008345081],"category_scores_gemma":[0.000003607025,0.00018682024,0.000048387366,0.00012362267,0.00020172574,0.000016147103,0.000031081418,0.00006422119,4.6712844e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002535006,0.00043773427,0.33881393,0.00013208941,0.00032871656,0.0000067690057,0.00032688922,0.0001168948,0.6470048,0.000092861206,0.000087589375,0.010116719],"study_design_scores_gemma":[0.013633027,0.0023480093,0.08829873,0.00029023626,0.00008313483,0.0000031158404,0.0002214122,0.00008912833,0.8704107,0.0002960789,0.023506524,0.00081989425],"about_ca_topic_score_codex":0.0064496645,"about_ca_topic_score_gemma":0.016793182,"teacher_disagreement_score":0.25051522,"about_ca_system_score_codex":0.000046403227,"about_ca_system_score_gemma":0.00010693583,"threshold_uncertainty_score":0.9750006},"labels":[],"label_agreement":null},{"id":"W2028113228","doi":"10.2147/ott.s57338","title":"Quality of life assessment in advanced cancer patients treated at home, an inpatient unit, and a day care center","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer survivorship and care","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Palliative care; Cancer; Performance status; Physical therapy; Activities of daily living; Internal medicine; Nursing","score_opus":0.01985701977311151,"score_gpt":0.32887012930092835,"score_spread":0.30901310952781685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028113228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569464,0.002915258,0.0000037161292,0.00009056758,0.00016419803,0.00032094133,0.00008940165,0.000012997325,0.00070830545],"genre_scores_gemma":[0.9964268,0.002789705,0.000031107655,0.00046305175,0.000035500434,0.000040923005,0.00014912558,0.000016947726,0.00004684371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898744,0.00014348084,0.00026321245,0.00024981698,0.0001929357,0.00016313739],"domain_scores_gemma":[0.9993902,0.000034022032,0.000107296844,0.00017876767,0.00013030332,0.00015939794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001361479,0.00014465723,0.0003759711,0.000064115164,0.000043526332,0.0000075323683,0.000035576224,0.00006017825,0.000063276464],"category_scores_gemma":[0.000008134104,0.00010878539,0.000034827066,0.00009273188,0.000049821618,0.00006492228,0.000026120731,0.00009149666,1.8963718e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006359532,0.00027336043,0.92270154,0.00007536984,0.000027063426,5.2072136e-7,0.004839668,0.0000014675118,0.0006088833,0.000030130841,0.000011851179,0.070794195],"study_design_scores_gemma":[0.0073411525,0.0012204727,0.9801732,0.00008069275,0.0000072469584,1.6312418e-7,0.000521744,0.000028925835,0.00035230708,0.00001750914,0.010126833,0.00012977421],"about_ca_topic_score_codex":0.0027719592,"about_ca_topic_score_gemma":0.009283407,"teacher_disagreement_score":0.07066442,"about_ca_system_score_codex":0.00008818672,"about_ca_system_score_gemma":0.000049119193,"threshold_uncertainty_score":0.5180359},"labels":[],"label_agreement":null},{"id":"W2054208824","doi":"10.2147/ott.s60358","title":"Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Radiosurgery; Temozolomide; Common Terminology Criteria for Adverse Events; Radiation therapy; Tolerability; Toxicity; Dose fractionation; Progression-free survival; Oncology; Nuclear medicine; Chemotherapy; Internal medicine; Radiology; Adverse effect","score_opus":0.010109574582131657,"score_gpt":0.2715641339687017,"score_spread":0.2614545593865701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054208824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924835,0.0011236306,0.00030413276,0.00078774634,0.00027023224,0.0047714603,0.000015284515,0.000092532544,0.0001514961],"genre_scores_gemma":[0.9967372,0.00095236563,0.00034906276,0.0003951934,0.00017340067,0.0012214143,0.000030720636,0.000060539816,0.00008010986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833494,0.000064537504,0.00033611598,0.00058564846,0.0003266192,0.0003521538],"domain_scores_gemma":[0.99878305,0.00024994073,0.00019855762,0.00028862813,0.00026531224,0.00021453662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003364625,0.00036334345,0.0006793644,0.00013045767,0.00019901227,0.000057522044,0.000053436936,0.00007876548,0.00007503504],"category_scores_gemma":[0.00003513374,0.00020939783,0.00012196619,0.00016557323,0.00008391279,0.000110635156,0.00001101997,0.00015608624,0.0000071253985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006123622,0.004823647,0.84661585,0.000030878637,0.0013478085,0.000028073619,0.0005482774,0.000002906832,0.00033496376,0.000071258466,0.00044922662,0.13962351],"study_design_scores_gemma":[0.031833116,0.022710342,0.90879744,0.00013653003,0.00021851268,0.00011279295,0.0002210152,0.0011276165,0.0032962412,0.00008107559,0.031082302,0.0003829859],"about_ca_topic_score_codex":0.000050442053,"about_ca_topic_score_gemma":0.00006231693,"teacher_disagreement_score":0.13924052,"about_ca_system_score_codex":0.0001504319,"about_ca_system_score_gemma":0.00008329428,"threshold_uncertainty_score":0.85389954},"labels":[],"label_agreement":null},{"id":"W2057735943","doi":"10.2147/ott.s63302","title":"Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institut National d'Excellence en Santé et en Services Sociaux; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Oncology; Metastatic breast cancer; Progression-free survival; Breast cancer; Confidence interval; Population; Surrogate endpoint; Cancer; Overall survival","score_opus":0.02274941579887847,"score_gpt":0.35614130633805935,"score_spread":0.3333918905391809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057735943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848699,0.0054089604,0.000065732806,0.006883179,0.000897168,0.00084501464,0.000108793865,0.000035769935,0.00088548183],"genre_scores_gemma":[0.99199677,0.00498747,0.00046630407,0.00085729756,0.0005245088,0.00023779657,0.00004495808,0.00003551333,0.0008493604],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998926,0.00008929474,0.00019359341,0.00028438444,0.00019131078,0.0003154043],"domain_scores_gemma":[0.9994525,0.000114320304,0.000070558024,0.00015841861,0.00006693789,0.00013729822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003251637,0.00018862312,0.00042435116,0.00006927777,0.00007364711,0.000020300182,0.000072181465,0.00005501338,0.00052970316],"category_scores_gemma":[0.000011973494,0.0001341079,0.00009572764,0.00007082033,0.00006109497,0.00006297517,0.000024618572,0.00010372344,0.0000036729757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029032191,0.0037899974,0.2936718,0.00033156617,0.0015960232,0.00019267207,0.0014370483,0.00004265625,0.031286076,0.0036536932,0.004754031,0.63021225],"study_design_scores_gemma":[0.13584727,0.0068103373,0.6146808,0.00038427167,0.0005852228,0.00020672646,0.0001600631,0.0035166957,0.003778792,0.017694315,0.21530399,0.0010315108],"about_ca_topic_score_codex":0.0009230896,"about_ca_topic_score_gemma":0.0004368643,"teacher_disagreement_score":0.6291807,"about_ca_system_score_codex":0.000050102215,"about_ca_system_score_gemma":0.00011220412,"threshold_uncertainty_score":0.57998776},"labels":[],"label_agreement":null},{"id":"W2072360921","doi":"10.2147/ott.s41397","title":"Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors","year":2013,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Neurofibromatosis; Neurofibroma; Schwannoma; Radiation therapy; Pathological; Malignant peripheral nerve sheath tumor; Nerve sheath neoplasm; Nerve sheath tumor; Surgery; Radiology; Pathology","score_opus":0.026105458024629942,"score_gpt":0.2581640071450141,"score_spread":0.23205854912038415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072360921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041593,0.0045276494,5.6259864e-7,0.004035817,0.0000633495,0.0005763804,0.000019147872,0.000018333612,0.00034282016],"genre_scores_gemma":[0.9931372,0.0058263,0.00014596552,0.00046313263,0.00013293997,0.00013140083,0.000007914504,0.000021116242,0.00013407045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918115,0.000052483818,0.000214075,0.00022983873,0.00013256236,0.00018985964],"domain_scores_gemma":[0.99946004,0.00011809475,0.00006724885,0.00020192603,0.00003883282,0.00011384957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006129639,0.0001941709,0.0003540787,0.000034382647,0.000111690686,0.000047761925,0.000040213912,0.000043042583,0.0005260578],"category_scores_gemma":[0.000008100432,0.000093696544,0.00008809772,0.000054172342,0.00011693201,0.0000625147,0.000012359433,0.000054117434,0.0000048287857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015970408,0.0031478275,0.58846235,0.00007621037,0.0005662076,0.0007108259,0.0035916157,0.000002557461,0.0835136,0.0053665885,0.004586787,0.3083784],"study_design_scores_gemma":[0.0066981036,0.020135479,0.8511873,0.00026421077,0.00010003037,0.0005057175,0.00071896537,0.00048792263,0.091768526,0.0010191764,0.026673287,0.00044127315],"about_ca_topic_score_codex":0.000482564,"about_ca_topic_score_gemma":0.0000053046087,"teacher_disagreement_score":0.30793712,"about_ca_system_score_codex":0.000015995021,"about_ca_system_score_gemma":0.000020877183,"threshold_uncertainty_score":0.5759964},"labels":[],"label_agreement":null},{"id":"W2078214711","doi":"10.2147/ott.s38403","title":"β-blockers: a novel class of antitumor agents","year":2012,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Fudan University; National Natural Science Foundation of China; National Science Foundation","keywords":"BETA (programming language); Class (philosophy); Pharmacology; Medicine; Chemistry; Computer science; Artificial intelligence; Programming language","score_opus":0.04348671431179846,"score_gpt":0.30943908477307996,"score_spread":0.2659523704612815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078214711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96543914,0.031728897,0.000045148765,0.0009111241,0.00028503494,0.00023858495,0.000012892894,0.000024760837,0.0013144452],"genre_scores_gemma":[0.98238856,0.013227214,0.000843092,0.000639773,0.00056109694,0.000012053511,0.000018367029,0.000029860812,0.0022799696],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990946,0.000028625007,0.00022396084,0.00015417165,0.00019276343,0.00030586918],"domain_scores_gemma":[0.99938124,0.000043246055,0.00010224349,0.00026239143,0.000056362285,0.00015452626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020309539,0.00015995516,0.0003789234,0.0000809299,0.00006204472,0.000010837941,0.00006040532,0.00007420495,0.00029927373],"category_scores_gemma":[0.000015173023,0.00012038678,0.00011561774,0.00010217046,0.00012160973,0.00010288615,0.000015898138,0.00010391827,0.000018630231],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0097531425,0.0048507894,0.49969634,0.000426439,0.001057197,0.000029259536,0.008601687,0.0000017600216,0.30845538,0.0013630326,0.042704333,0.12306062],"study_design_scores_gemma":[0.002947133,0.00029727354,0.1669767,0.00008883267,0.000035846897,0.000099953744,0.00012553028,0.000012982377,0.007239481,0.000010890645,0.8220306,0.00013478629],"about_ca_topic_score_codex":0.00014260704,"about_ca_topic_score_gemma":0.000006544689,"teacher_disagreement_score":0.77932626,"about_ca_system_score_codex":0.000022999853,"about_ca_system_score_gemma":0.00006568084,"threshold_uncertainty_score":0.49092302},"labels":[],"label_agreement":null},{"id":"W2088964260","doi":"10.2147/ott.s59227","title":"Cancer cell-oriented migration of mesenchymal stem cells engineered with an anticancer gene (PTEN): an imaging demonstration","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of British Columbia; Natural Science Foundation of Guangxi Province","keywords":"PTEN; Tensin; Mesenchymal stem cell; Cancer research; Cell; Cell migration; Gene delivery; Transfection; Cancer cell; Stem cell; Biology; Cell culture; Cancer; Cell biology; PI3K/AKT/mTOR pathway; Signal transduction; Genetics","score_opus":0.015285918774809263,"score_gpt":0.28121630622995464,"score_spread":0.26593038745514536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088964260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247724,0.002301272,0.0036030305,0.00021169637,0.000081226135,0.00045473978,0.000010687053,0.000035459198,0.00082462287],"genre_scores_gemma":[0.99436617,0.0024693129,0.0025798623,0.00009595966,0.00018464228,0.000028381828,0.000030922653,0.000032766464,0.00021200822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986087,0.000104546205,0.00024861013,0.00033936306,0.00041571393,0.0002830523],"domain_scores_gemma":[0.9990843,0.000038811962,0.0000997447,0.00028420362,0.00024558,0.0002473553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034942158,0.00018117235,0.00030417752,0.00007151109,0.00008490366,0.00002771239,0.00006623858,0.000061914245,0.00016576627],"category_scores_gemma":[0.000002865182,0.00012801707,0.00003426387,0.00014920648,0.00009041256,0.0002751863,0.000009507429,0.00012008691,0.0000013604614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007211183,0.00027358398,0.062303875,0.00006674853,0.00004415489,0.000006389113,0.0007392306,0.000063107414,0.8730095,0.00014460529,0.000029804549,0.06259788],"study_design_scores_gemma":[0.0035361943,0.0022954247,0.03866747,0.00008830466,0.00004662461,0.000016886159,0.0004304491,0.07624326,0.87443626,0.000023528646,0.0039553978,0.00026017666],"about_ca_topic_score_codex":0.0012218239,"about_ca_topic_score_gemma":0.00048213976,"teacher_disagreement_score":0.076180145,"about_ca_system_score_codex":0.000048599013,"about_ca_system_score_gemma":0.0001156939,"threshold_uncertainty_score":0.52203846},"labels":[],"label_agreement":null},{"id":"W2092597257","doi":"10.2147/ott.s71089","title":"Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis","year":2015,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Thymidine phosphorylase; Capecitabine; Breast cancer; Medicine; Oncology; Estrogen receptor; Internal medicine; Immunohistochemistry; Cancer; Progesterone receptor; Tumor progression; Stage (stratigraphy); Metastatic breast cancer; Clinical significance; Pathology; Biology; Colorectal cancer","score_opus":0.035540847519078336,"score_gpt":0.2834232823298414,"score_spread":0.24788243481076305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092597257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955985,0.0028723078,0.000013394885,0.00014783835,0.00003734181,0.0011717691,0.000034824498,0.000011573665,0.00011245002],"genre_scores_gemma":[0.9993676,0.00019028354,0.0001638471,0.000043908472,0.000017866703,0.00018632112,0.000008995537,0.00000936468,0.00001184751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909276,0.00007128947,0.00020260086,0.0002371138,0.00026102783,0.00013523948],"domain_scores_gemma":[0.9993955,0.000044037886,0.00014988413,0.0001350121,0.00020163378,0.00007396063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017110554,0.00014947668,0.00040621107,0.00008147125,0.00008845952,0.000013123443,0.000038391296,0.000008970304,0.000009973863],"category_scores_gemma":[0.000032007058,0.00007467467,0.000027905944,0.0005694535,0.00013931403,0.00007649194,0.000020619213,0.00008551875,1.4503487e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021730466,0.0027526075,0.98726773,0.000010809,0.00067009183,0.000005950991,0.0029030908,0.00007259927,0.0004067439,0.0000052883297,0.000010302025,0.003721716],"study_design_scores_gemma":[0.00615051,0.010459235,0.98116666,0.00009766036,0.00037446886,7.8296074e-7,0.00095272984,0.00006288883,0.000577604,0.00005572414,0.00001612979,0.00008558318],"about_ca_topic_score_codex":0.001956806,"about_ca_topic_score_gemma":0.001576043,"teacher_disagreement_score":0.0077066277,"about_ca_system_score_codex":0.00016519561,"about_ca_system_score_gemma":0.00010037416,"threshold_uncertainty_score":0.30451444},"labels":[],"label_agreement":null},{"id":"W2093544818","doi":"10.2147/ott.s30238","title":"Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options","year":2013,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Ovarian cancer; Olaparib; Oncology; Internal medicine; Chemotherapy; Systemic therapy; Bevacizumab; Clinical trial; Cancer; Polymerase; Breast cancer; Poly ADP ribose polymerase","score_opus":0.027344287524817407,"score_gpt":0.30800633036633196,"score_spread":0.2806620428415145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093544818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91917783,0.07195792,0.00019249291,0.0044363923,0.0005246282,0.0032644514,0.00017372768,0.000058814385,0.00021373683],"genre_scores_gemma":[0.8468859,0.14539923,0.0006683791,0.00039615907,0.00048759204,0.005850371,0.000032641325,0.000041180858,0.00023854314],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99878436,0.000036308746,0.00022879051,0.00039525115,0.00017727652,0.00037801554],"domain_scores_gemma":[0.9991586,0.0000625076,0.00012344409,0.00022698566,0.00019365935,0.00023480336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010808248,0.00026437914,0.00042930915,0.000063261694,0.00016578636,0.00006045929,0.000059786318,0.00005852099,0.00048688427],"category_scores_gemma":[0.0000032426067,0.00015793595,0.00007378697,0.00010412115,0.0000618192,0.0000913519,0.000009276966,0.00011459394,0.000013347212],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016247589,0.0011406159,0.044879198,0.000110020155,0.0008768361,0.0000041922144,0.0027716581,0.000006017317,0.0011346331,0.0012354682,0.0014559777,0.9447606],"study_design_scores_gemma":[0.03411679,0.009426905,0.5048835,0.0010089746,0.00011759781,0.00002613863,0.00062604266,0.00027788477,0.0014201785,0.0025384903,0.44486737,0.0006900901],"about_ca_topic_score_codex":0.00023446945,"about_ca_topic_score_gemma":0.000019536923,"teacher_disagreement_score":0.9440705,"about_ca_system_score_codex":0.00024576517,"about_ca_system_score_gemma":0.0001912493,"threshold_uncertainty_score":0.64404416},"labels":[],"label_agreement":null},{"id":"W2106504686","doi":"10.2147/ott.s14503","title":"Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells","year":2010,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Hôpital Notre-Dame","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Université du Québec à Montréal","keywords":"Protein kinase B; Propranolol; Phosphorylation; Signal transduction; MAPK/ERK pathway; Kinase; Pharmacology; Cell biology; Chemistry; Cancer research; Biology; Endocrinology; Internal medicine; Medicine","score_opus":0.015973263898780725,"score_gpt":0.27814749082608886,"score_spread":0.26217422692730813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106504686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883619,0.010065505,0.000044537992,0.0004610011,0.00044612156,0.00030317673,0.000013494603,0.000042202173,0.00026209382],"genre_scores_gemma":[0.98599565,0.01107771,0.0013680819,0.00016700117,0.0004909079,0.00003322876,0.000057012778,0.000028621378,0.00078180904],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868464,0.00010908569,0.0003831476,0.00033153594,0.00019010628,0.00030147217],"domain_scores_gemma":[0.99925315,0.00021136801,0.00014910303,0.0001376209,0.000090773996,0.00015799674],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044720166,0.00022633422,0.00045345962,0.0001526194,0.00013375889,0.000026057753,0.00006352843,0.0001815472,0.0012493822],"category_scores_gemma":[0.00003869056,0.00017627866,0.000097621276,0.00018293793,0.00023232237,0.00009467748,0.000022955473,0.00037849284,0.000011233937],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017302127,0.00025343083,0.010348949,0.0000452475,0.00007094257,0.0000050868225,0.0006749199,0.000019631343,0.9726997,0.000029773104,0.00085882563,0.013263288],"study_design_scores_gemma":[0.007331044,0.0011720962,0.023557702,0.00022704361,0.00011881088,0.000091133545,0.00065739464,0.00029093132,0.36126256,0.00014177733,0.6046233,0.0005261719],"about_ca_topic_score_codex":0.00018743033,"about_ca_topic_score_gemma":0.00008765576,"teacher_disagreement_score":0.61143714,"about_ca_system_score_codex":0.00002369115,"about_ca_system_score_gemma":0.000074855736,"threshold_uncertainty_score":0.9996636},"labels":[],"label_agreement":null},{"id":"W2114890848","doi":"10.2147/ott.s62717","title":"Transcriptional targeting of sphingosine-1- phosphate receptor S1P2 by epigallocatechin- 3-gallate prevents sphingosine-1-phosphate- mediated signaling in macrophage-differentiated HL-60 promyelomonocytic leukemia cells","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Université du Québec à Montréal","keywords":"Neuroinflammation; Cell biology; Kinase; Signal transduction; MAPK/ERK pathway; Sphingosine kinase; p38 mitogen-activated protein kinases; Sphingosine; Cancer research; Sphingosine-1-phosphate; Biology; Receptor; Inflammation; Immunology; Biochemistry","score_opus":0.006424711646603753,"score_gpt":0.21503700845133011,"score_spread":0.20861229680472637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114890848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761904,0.021271642,0.0012754897,0.00007364954,0.00047822215,0.00052961113,0.000073726645,0.000046581667,0.00006068928],"genre_scores_gemma":[0.98908776,0.007930469,0.0014867653,0.00027066414,0.00025831684,0.00004156776,0.0005943098,0.00010277937,0.00022734333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99697906,0.00024335955,0.00091260014,0.00081850047,0.00036219234,0.0006843064],"domain_scores_gemma":[0.9988369,0.000060323546,0.00040930082,0.00032884668,0.00013187715,0.00023279681],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009907674,0.0005461713,0.0007039045,0.00013090775,0.0001793223,0.00007374974,0.00037359417,0.0003626649,0.00016258602],"category_scores_gemma":[0.00007660496,0.0004953575,0.00019242153,0.0002714742,0.00014374354,0.000037629354,0.0000759855,0.0003347387,0.0000073099486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005633024,0.00018311724,0.0024700654,0.000093553404,0.00014233003,0.000003447218,0.00037160414,0.00058263366,0.99132156,0.000034739554,0.00026222662,0.003971408],"study_design_scores_gemma":[0.0046642083,0.0003314447,0.0020713399,0.00014547662,0.000033710767,0.000003108524,0.000048089038,0.0027698812,0.9689077,0.00016733774,0.020272337,0.0005853467],"about_ca_topic_score_codex":0.00039337622,"about_ca_topic_score_gemma":0.000012138192,"teacher_disagreement_score":0.022413854,"about_ca_system_score_codex":0.000052324638,"about_ca_system_score_gemma":0.00012805048,"threshold_uncertainty_score":0.9997498},"labels":[],"label_agreement":null},{"id":"W2120430486","doi":"10.2147/ott.s87580","title":"Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis","year":2015,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Hepatectomy; Internal medicine; Splenectomy; Gastroenterology; Confidence interval; Perioperative; Cochrane Library; Meta-analysis; White blood cell; Surgery; Spleen","score_opus":0.1711694128655097,"score_gpt":0.3016819767570187,"score_spread":0.13051256389150898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120430486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91910106,0.07671108,0.00036176818,0.0013540024,0.000071387185,0.0017421212,0.00025090147,0.0001405601,0.0002671042],"genre_scores_gemma":[0.9939176,0.0017640194,0.0022027213,0.00038433413,0.00008862846,0.00043439714,0.00067155814,0.00008395479,0.00045283162],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754745,0.00013554336,0.00046210364,0.00087767834,0.00038855855,0.000588643],"domain_scores_gemma":[0.9979122,0.00038497677,0.00016742718,0.0005150278,0.0003251426,0.000695179],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040557355,0.00058770867,0.0018996535,0.00025963612,0.00022284914,0.00009473092,0.00012385123,0.00023181074,0.00016273295],"category_scores_gemma":[0.000049843144,0.00043336028,0.00082793075,0.0005171883,0.00016472314,0.00010688836,0.000051524206,0.00018254158,0.000012499573],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008311683,0.0011058974,0.84704524,0.00012780214,0.12265736,0.0005914854,0.0013862216,0.000005886697,0.00975537,0.00009835302,0.0018318669,0.007082807],"study_design_scores_gemma":[0.080518655,0.014068284,0.0043466925,0.00001993974,0.27567133,0.00031801255,0.0005697978,0.16732985,0.06675678,0.0006189505,0.3869722,0.0028095003],"about_ca_topic_score_codex":0.0011824,"about_ca_topic_score_gemma":0.000034093828,"teacher_disagreement_score":0.8426986,"about_ca_system_score_codex":0.00008225491,"about_ca_system_score_gemma":0.00009647275,"threshold_uncertainty_score":0.9998118},"labels":[],"label_agreement":null},{"id":"W2320733543","doi":"10.2147/ott.s97436","title":"Concurrent cisplatin-based chemoradiotherapy versus exclusive radiotherapy in high-risk cervical cancer: a meta-analysis","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cervical cancer; Cisplatin; Chemoradiotherapy; Medicine; Radiation therapy; Oncology; Meta-analysis; Internal medicine; Radiology; Cancer; Chemotherapy","score_opus":0.056964517858168244,"score_gpt":0.3392702648888527,"score_spread":0.28230574703068445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320733543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8858401,0.101607874,0.0010841971,0.00953637,0.0004484909,0.0009219081,0.00025610765,0.00007835572,0.00022657194],"genre_scores_gemma":[0.9590048,0.037857927,0.0006893641,0.00153035,0.00029004953,0.00027328494,0.000025620233,0.000044999502,0.0002835771],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99786955,0.00017320098,0.00045771096,0.00064237247,0.00041638946,0.0004407626],"domain_scores_gemma":[0.99848545,0.0005505713,0.00021286852,0.00038068581,0.00007310465,0.00029729644],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022855322,0.00040688706,0.0018060898,0.00036391398,0.00009332565,0.00002787819,0.00012516316,0.00015555669,0.0057848063],"category_scores_gemma":[0.000021856351,0.00021334956,0.0008345086,0.00093452586,0.00013554949,0.00007641188,0.000014306237,0.00017701132,0.000005851241],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01336639,0.0014684253,0.19351126,0.000040141167,0.13890977,0.000106063366,0.0004068192,0.00007772573,0.0029482178,0.00040684262,0.00013407698,0.64862424],"study_design_scores_gemma":[0.3467971,0.012926856,0.40507856,0.00010540614,0.118061095,0.000012416369,0.00009177414,0.0018948496,0.022902772,0.0010537981,0.08879232,0.0022830553],"about_ca_topic_score_codex":0.0015269862,"about_ca_topic_score_gemma":0.0003297741,"teacher_disagreement_score":0.6463412,"about_ca_system_score_codex":0.000234941,"about_ca_system_score_gemma":0.00012403159,"threshold_uncertainty_score":0.99512404},"labels":[],"label_agreement":null},{"id":"W2325418286","doi":"10.2147/ott.s104004","title":"Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: comments on a meta-analysis by Liang et al","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Science Foundation of Hunan Province; National Natural Science Foundation of China","keywords":"Medicine; Bone Sarcoma; Soft tissue; Osteosarcoma; Meta-analysis; Sarcoma; Subgroup analysis; Value (mathematics); Soft tissue sarcoma; Orthopedic surgery; Oncology; Internal medicine; Pathology; Surgery; Computer science","score_opus":0.0397497882919545,"score_gpt":0.3303150941496893,"score_spread":0.29056530585773477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325418286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92210203,0.06183713,0.000059763253,0.015301756,0.00001861522,0.0004737353,0.00006176653,0.000013480904,0.0001317371],"genre_scores_gemma":[0.9886978,0.007086767,0.0005092773,0.0034261607,0.000008319145,0.00009217552,0.00002318215,0.000016971882,0.000139293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989246,0.00011158982,0.00026923063,0.0003002011,0.00022004031,0.0001743056],"domain_scores_gemma":[0.99920464,0.00033790353,0.000106697276,0.00021719451,0.000027586022,0.00010597598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023501694,0.00018502316,0.00078147737,0.0001395578,0.000036169135,0.000012118398,0.000033534157,0.00005172985,0.0001807744],"category_scores_gemma":[0.00002632923,0.00009352214,0.0001710157,0.00012597008,0.00005193111,0.00005502436,0.000023794237,0.00006175691,0.0000028212655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075182825,0.004601023,0.81682426,0.000030848787,0.020788219,0.00013563101,0.00084311474,0.0000017521135,0.050772186,0.00024083388,0.0076521733,0.09735813],"study_design_scores_gemma":[0.021016117,0.0048487773,0.64761287,0.00038242034,0.021290904,0.000031160835,0.00014250867,0.00009899577,0.10853651,0.00092739513,0.19448924,0.0006230799],"about_ca_topic_score_codex":0.00014277191,"about_ca_topic_score_gemma":0.00002141584,"teacher_disagreement_score":0.18683708,"about_ca_system_score_codex":0.000022039096,"about_ca_system_score_gemma":0.00001401553,"threshold_uncertainty_score":0.3813722},"labels":[],"label_agreement":null},{"id":"W2346886569","doi":"10.2147/ott.s102286","title":"Haploidentical hematopoietic stem cell transplantation without total body irradiation for pediatric acute leukemia: a single-center experience","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"Specialized Research Fund for the Doctoral Program of Higher Education of China; Beijing Municipal Administration of Hospitals; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; National Natural Science Foundation of China","keywords":"Medicine; Hematopoietic stem cell transplantation; Total body irradiation; Hematology; Transplantation; Single Center; Leukemia; Internal medicine; Myeloid leukemia; Stem cell; Christian ministry; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.019295167692144927,"score_gpt":0.2682242362239413,"score_spread":0.2489290685317964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346886569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97829384,0.0005455841,0.019165944,0.00037105597,0.00025056882,0.00094141334,0.000050447674,0.000076673,0.00030445508],"genre_scores_gemma":[0.99427503,0.0033718662,0.0010378691,0.00016984281,0.00020493922,0.00015801741,0.00004084546,0.000043710104,0.0006978559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860364,0.000038105038,0.00037161482,0.00038869015,0.00028142377,0.00031652374],"domain_scores_gemma":[0.99931747,0.00014521618,0.000107513835,0.00016998214,0.0000811376,0.00017866894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013277779,0.00022105096,0.00032254,0.000100384255,0.000104253624,0.000037813446,0.000055640066,0.00013965969,0.00006560765],"category_scores_gemma":[0.0000033769338,0.00014969238,0.000105572544,0.00009218111,0.000057322475,0.00021236291,0.000004677182,0.000071202776,0.000019221994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038382239,0.0009735589,0.22908755,0.0011532577,0.00019038547,0.00012634217,0.015695088,0.0000015088075,0.7309881,0.00064769294,0.00023807038,0.017060231],"study_design_scores_gemma":[0.09430527,0.008220457,0.25912806,0.0012288515,0.0018703688,0.004297985,0.0014858939,0.0013432654,0.619323,0.0010396725,0.0053759385,0.0023812156],"about_ca_topic_score_codex":0.0000049648906,"about_ca_topic_score_gemma":0.0000014165088,"teacher_disagreement_score":0.11166506,"about_ca_system_score_codex":0.000099485944,"about_ca_system_score_gemma":0.00007641696,"threshold_uncertainty_score":0.6104278},"labels":[],"label_agreement":null},{"id":"W2375133443","doi":"10.2147/ott.s102578","title":"Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"Pfizer","keywords":"Axitinib; Medicine; Internal medicine; Sunitinib; Renal cell carcinoma; Oncology; Regimen; Response Evaluation Criteria in Solid Tumors; Cancer; Progressive disease; Disease","score_opus":0.05487739526461042,"score_gpt":0.3388670856391863,"score_spread":0.2839896903745759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2375133443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499816,0.0023322008,0.0000039482024,0.00024137182,0.00008266647,0.002105728,0.00007894555,0.000012861278,0.0001441134],"genre_scores_gemma":[0.9989553,0.00010445154,0.00041025982,0.000038028942,0.000029711371,0.00024322885,0.0001224976,0.000042583426,0.00005391948],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99483484,0.0027197166,0.0005867528,0.00050506066,0.0010367677,0.00031688545],"domain_scores_gemma":[0.9980281,0.00055850856,0.000244971,0.0004025338,0.00063319545,0.00013267405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037391197,0.00030444356,0.0005806056,0.00035070616,0.000039186187,0.000019961033,0.00007185918,0.00007757014,0.0008764357],"category_scores_gemma":[0.00035928402,0.00018675542,0.00006755467,0.00020326042,0.00009336359,0.00017511735,0.000018551273,0.00009277839,0.000007403665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34246784,0.001619204,0.26318842,0.000033039578,0.00018780079,0.00008928571,0.0052144984,0.000012436177,0.3511095,9.0596086e-7,0.000054244465,0.03602284],"study_design_scores_gemma":[0.060258824,0.0067669996,0.8840778,0.00029882105,0.00031776962,0.0000035521039,0.00012889825,0.0006022015,0.04721195,0.000074287884,0.00006431077,0.00019460429],"about_ca_topic_score_codex":0.00051040197,"about_ca_topic_score_gemma":0.00014096205,"teacher_disagreement_score":0.62088937,"about_ca_system_score_codex":0.0006335014,"about_ca_system_score_gemma":0.0005318178,"threshold_uncertainty_score":0.9596357},"labels":[],"label_agreement":null},{"id":"W2464322340","doi":"10.2147/ott.s104334","title":"Association between pesticide exposure and risk of kidney cancer: a meta-analysis","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Meta-analysis; Kidney cancer; Medicine; Environmental health; Cancer; Pesticide; Oncology; Toxicology; Internal medicine; Biology; Ecology","score_opus":0.017280140937013473,"score_gpt":0.27008138252475355,"score_spread":0.2528012415877401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464322340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9376532,0.059535988,0.00053578784,0.0010327458,0.00039291065,0.00011965377,0.0005921417,0.0000062151603,0.00013138483],"genre_scores_gemma":[0.8397565,0.15507798,0.00025594345,0.00031229694,0.002420965,0.000032210366,0.00003288592,0.000015727437,0.0020955086],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992411,0.00008835556,0.00017808554,0.00024113382,0.0001093288,0.00014200507],"domain_scores_gemma":[0.99938226,0.000039325463,0.00020340527,0.00016463514,0.00008325098,0.00012714442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002854676,0.000121636185,0.0004506166,0.000042978572,0.00005125201,0.000010650437,0.00005461506,0.00010552165,0.00010452669],"category_scores_gemma":[0.00009005084,0.00007302973,0.0002523545,0.00007312818,0.000041705942,0.0000048285183,0.000022053353,0.00003573019,3.9154497e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007542008,0.000028532611,0.8186721,0.000007495084,0.07261153,2.7910954e-8,0.00011570157,0.000002438765,0.07718935,0.00002903144,0.0069782212,0.024290131],"study_design_scores_gemma":[0.0012817903,0.00020529544,0.19100542,0.0000028871757,0.03109573,3.451746e-7,0.000011817442,0.0000020709183,0.0225099,0.00022814432,0.75346774,0.00018887936],"about_ca_topic_score_codex":0.0004508973,"about_ca_topic_score_gemma":0.00018696468,"teacher_disagreement_score":0.7464895,"about_ca_system_score_codex":0.000008324146,"about_ca_system_score_gemma":0.000057042966,"threshold_uncertainty_score":0.29780662},"labels":[],"label_agreement":null},{"id":"W2528485638","doi":"10.2147/ott.s110203","title":"Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Natural Science Foundation of Zhejiang Province","keywords":"Downregulation and upregulation; Cancer; Medicine; Internal medicine; Oncology; Cancer research; Biology; Gene","score_opus":0.0054475422700657455,"score_gpt":0.21508752687669713,"score_spread":0.20963998460663139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528485638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812454,0.0011706932,0.0001789101,0.00015938701,0.000019069674,0.0002214581,0.0000826013,0.000004004774,0.000039347393],"genre_scores_gemma":[0.99861246,0.00096221344,0.00014345546,0.000029806508,0.000029360132,0.000018332197,0.00005448041,0.00001535819,0.00013451921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994387,0.000020943422,0.00013129025,0.0001720505,0.00013217448,0.00010482956],"domain_scores_gemma":[0.9994574,0.0000072961066,0.00020128845,0.0000964857,0.00020816659,0.000029339628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046053206,0.00009787352,0.00013307348,0.000032857624,0.000023663235,0.000003084632,0.000037809514,0.00007649986,0.000038491457],"category_scores_gemma":[0.00000484228,0.00005500174,0.000026148502,0.000097205426,0.00007293047,0.000006165891,0.000009147837,0.000016696114,1.2316292e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010401077,0.0001738346,0.51151675,0.0000093526305,0.00033652026,9.696391e-8,0.00007304322,0.000038196147,0.4129546,0.0000079966985,0.0003065295,0.07354294],"study_design_scores_gemma":[0.0030033856,0.0012227626,0.71639514,0.00008038636,0.000025755908,3.3591292e-7,0.0000037844766,0.000016065058,0.27713075,0.000017664057,0.001994768,0.00010918378],"about_ca_topic_score_codex":0.00003885052,"about_ca_topic_score_gemma":0.000051764047,"teacher_disagreement_score":0.20487839,"about_ca_system_score_codex":0.000015787426,"about_ca_system_score_gemma":0.00005115055,"threshold_uncertainty_score":0.22429058},"labels":[],"label_agreement":null},{"id":"W2549312266","doi":"10.2147/ott.s109650","title":"Effect of smoking on the genetic makeup of toll-like receptors 2 and 6","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"TLR2; Single-nucleotide polymorphism; Genotype; SNP; Medicine; Population; Innate immune system; Cotinine; Immunology; Saliva; Receptor; Nicotine; Internal medicine; Biology; Gene; Genetics; Environmental health","score_opus":0.006602049319220464,"score_gpt":0.22510039657051953,"score_spread":0.21849834725129907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549312266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98956203,0.009406172,0.000010235386,0.00031947953,0.0002545062,0.00014432802,0.0000020861874,0.0000061193978,0.0002950676],"genre_scores_gemma":[0.9936313,0.005709133,0.000005526953,0.000051317493,0.000010562765,0.0000069505777,0.0000015514167,0.000006220092,0.00057743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938077,0.00026011743,0.00014556047,0.00009356476,0.000021011221,0.00009900567],"domain_scores_gemma":[0.9992998,0.0004598583,0.000090067486,0.00012732732,0.000017252418,0.000005691173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003361523,0.00008391961,0.00016556043,0.000037870945,0.00006243452,0.0000026309906,0.000053515734,0.00007860862,0.00021229994],"category_scores_gemma":[0.000025753607,0.000036648824,0.000035332065,0.000027969627,0.00015354439,0.00002415203,0.000014978714,0.00004713912,0.0000063641323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009457512,0.000015807966,0.005605877,0.000009751022,0.00009688239,3.2576946e-7,0.00027459787,1.0148485e-7,0.68057245,0.0004265438,0.00033165928,0.31172025],"study_design_scores_gemma":[0.0016593259,0.0017364143,0.01962687,0.000077296165,0.000011818746,0.000008651721,0.00002222629,5.805959e-7,0.90427655,0.00014284963,0.07237029,0.00006715429],"about_ca_topic_score_codex":0.000014792251,"about_ca_topic_score_gemma":8.1415186e-7,"teacher_disagreement_score":0.3116531,"about_ca_system_score_codex":0.0000043472096,"about_ca_system_score_gemma":0.000008177278,"threshold_uncertainty_score":0.23245354},"labels":[],"label_agreement":null},{"id":"W2562421369","doi":"10.2147/ott.s106024","title":"Association between <em>TLR-9</em> polymorphisms and colon cancer susceptibility in Saudi Arabian female patients","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Colorectal cancer; Internal medicine; Association (psychology); Cancer; Oncology; Psychology","score_opus":0.011239788867495772,"score_gpt":0.2406227111290439,"score_spread":0.22938292226154813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562421369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993224,0.008119533,0.000010397651,0.0009322094,0.0003677125,0.00037991055,0.000059210008,0.000032927474,0.00016586506],"genre_scores_gemma":[0.9905828,0.0066503636,0.0000131923225,0.0001422195,0.00006798727,0.000038075323,0.000079856836,0.000018164783,0.0024073415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843794,0.00035348994,0.00037928412,0.00035462805,0.00007518816,0.0003994501],"domain_scores_gemma":[0.99919564,0.00022815652,0.0002460573,0.00019433245,0.00010177914,0.000034026547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062316883,0.00021275443,0.0003752067,0.00011320792,0.00019599493,0.000027423283,0.0000968396,0.00035641604,0.00043224875],"category_scores_gemma":[0.00008129336,0.00015170769,0.00005867415,0.00010278115,0.00009200393,0.00023361463,0.000041777494,0.00014969808,0.00005584235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046893655,0.000096845615,0.6035377,0.000006406476,0.00014115567,8.080382e-7,0.001166534,1.2752855e-7,0.27549604,0.00004379983,0.0005402884,0.11850142],"study_design_scores_gemma":[0.0042424053,0.00042623965,0.89695704,0.00006312882,0.000021007912,9.1515517e-7,0.000039788643,9.303262e-7,0.04156181,0.00025885017,0.05620079,0.00022706835],"about_ca_topic_score_codex":0.00019673088,"about_ca_topic_score_gemma":0.0008714096,"teacher_disagreement_score":0.29341942,"about_ca_system_score_codex":0.00019411714,"about_ca_system_score_gemma":0.00005561035,"threshold_uncertainty_score":0.618646},"labels":[],"label_agreement":null},{"id":"W2570540133","doi":"10.2147/ott.s124417","title":"RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Thyroid cancer; Medicine; Breast cancer; Meta-analysis; Odds ratio; Methylation; Oncology; Publication bias; Thyroid; Internal medicine; Cancer; Gynecology; Biology; Genetics","score_opus":0.03230625972315221,"score_gpt":0.30201787895836035,"score_spread":0.26971161923520814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570540133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785125,0.019783909,0.00089240965,0.00016059984,0.000018716104,0.00017691668,0.00014203202,0.0000042367706,0.00030863044],"genre_scores_gemma":[0.9896937,0.00943349,0.0004356603,0.00006372148,0.000040126917,0.00002741611,0.000081801154,0.000015464728,0.0002086278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991305,0.000121716934,0.00018286007,0.00028559368,0.00014963203,0.00012973422],"domain_scores_gemma":[0.9988361,0.00002042884,0.00048218467,0.0004393473,0.00016615134,0.000055780907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004398675,0.00014974688,0.000421116,0.000049220198,0.00020504133,0.000047036887,0.00012168526,0.000113360155,0.00008285886],"category_scores_gemma":[0.000050682098,0.00009945942,0.00027329472,0.00006626098,0.000080358885,0.000007640478,0.000029410032,0.000056431054,2.8119334e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032992402,0.00020854187,0.31436604,0.000008168106,0.10845299,0.0000016032267,0.00033066253,0.00014947155,0.5676258,0.000026132868,0.000059744616,0.008440925],"study_design_scores_gemma":[0.00172307,0.0007985549,0.26687717,0.0000035548253,0.02097667,2.1120842e-7,0.000011396448,0.00048468978,0.70370257,0.0006376106,0.004487737,0.0002967543],"about_ca_topic_score_codex":0.0010138056,"about_ca_topic_score_gemma":0.00060485565,"teacher_disagreement_score":0.13607676,"about_ca_system_score_codex":0.0000057628313,"about_ca_system_score_gemma":0.000037497215,"threshold_uncertainty_score":0.40558374},"labels":[],"label_agreement":null},{"id":"W2583057834","doi":"10.2147/ott.s122774","title":"Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China; Qilu Hospital of Shandong University; Shandong University","keywords":"Hazard ratio; Meta-analysis; Medicine; Confidence interval; Internal medicine; Oncology; Publication bias; Lung cancer; Subgroup analysis; Malignancy; microRNA; Cancer; Biology; Gene","score_opus":0.0348696962660097,"score_gpt":0.31496434468289025,"score_spread":0.28009464841688053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583057834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276274,0.006573218,0.00012370896,0.00009311257,0.000016543188,0.00028958125,0.000042268286,0.0000041630033,0.00009464079],"genre_scores_gemma":[0.99883294,0.00033530052,0.00042508956,0.00006876644,0.00003458658,0.000029421593,0.00016416903,0.000013263008,0.000096479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991516,0.00007975558,0.00023559347,0.00030731648,0.000080173726,0.00014554766],"domain_scores_gemma":[0.9990424,0.0000057649413,0.00025024434,0.0005621362,0.00007799899,0.00006144146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021197637,0.00013516571,0.00044003723,0.0000634882,0.00008172999,0.000041814,0.00020874335,0.000074888725,0.00008353114],"category_scores_gemma":[0.0000219677,0.00010640379,0.00021204207,0.000063530424,0.00010956641,0.000010582175,0.000037576312,0.000038818245,7.6174285e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011827859,0.00019220765,0.021493731,0.000032762146,0.0080381995,0.0000042555703,0.00006127299,0.00006974769,0.9696308,0.000025386516,0.000043473647,0.0002899157],"study_design_scores_gemma":[0.0010813654,0.000417124,0.27764615,0.00001386375,0.007231563,0.0000029026046,0.000029948142,0.00032109878,0.7105785,0.00035786824,0.0019387376,0.0003808825],"about_ca_topic_score_codex":0.00012556631,"about_ca_topic_score_gemma":0.00015186513,"teacher_disagreement_score":0.25905228,"about_ca_system_score_codex":0.000004728789,"about_ca_system_score_gemma":0.000038649683,"threshold_uncertainty_score":0.43390208},"labels":[],"label_agreement":null},{"id":"W2586120920","doi":"10.2147/ott.s111971","title":"Two SNPs in the promoter region of Toll-like receptor 4 gene are not associated with smoking in Saudi Arabia","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Single-nucleotide polymorphism; Genotype; TLR4; Saliva; Gene; SNP; Polymerase chain reaction; Biology; Polymorphism (computer science); Toll-like receptor; Population; Genetics; Immunology; Receptor; Medicine; Innate immune system; Internal medicine; Environmental health","score_opus":0.023291453695013554,"score_gpt":0.25611847112623537,"score_spread":0.2328270174312218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586120920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960941,0.0020759238,0.000005788968,0.0010851873,0.00013884883,0.00025219264,0.0000033549686,0.0000074006957,0.00033717215],"genre_scores_gemma":[0.9981055,0.0013033448,0.00001401535,0.0001808112,0.00001598473,0.000019660014,0.000026006775,0.000009146316,0.0003255227],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991484,0.00026883793,0.00020773849,0.0001530756,0.000036367124,0.00018554566],"domain_scores_gemma":[0.9993109,0.00007554017,0.00029449118,0.0002765326,0.00003706471,0.0000054803695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005396464,0.0001139778,0.00023322624,0.000066214205,0.00018179273,0.000025007916,0.00017583935,0.00012755823,0.000033662032],"category_scores_gemma":[0.00004465726,0.000069163725,0.000032006083,0.000046931757,0.00012624897,0.00012596883,0.000020641328,0.00019293417,0.0000034793702],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004275914,0.00054055685,0.307983,0.000019610077,0.0003000446,0.000061550934,0.009296509,0.00000617397,0.63577336,0.0005237661,0.0006344831,0.04058502],"study_design_scores_gemma":[0.0061767804,0.00047255002,0.84053904,0.00025903797,0.000010443547,0.00003199313,0.00030814117,0.000007650163,0.13797168,0.000247923,0.013780424,0.00019433288],"about_ca_topic_score_codex":0.00023769028,"about_ca_topic_score_gemma":0.0002831363,"teacher_disagreement_score":0.532556,"about_ca_system_score_codex":0.000023422304,"about_ca_system_score_gemma":0.00002571747,"threshold_uncertainty_score":0.2820415},"labels":[],"label_agreement":null},{"id":"W2592172886","doi":"10.2147/ott.s112165","title":"Toll-like receptor-4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Breast cancer; Medicine; Estrogen receptor; Toll-like receptor; Oncology; Receptor; Internal medicine; Estrogen; Cancer; Innate immune system","score_opus":0.019198467815052953,"score_gpt":0.32422625563115176,"score_spread":0.3050277878160988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592172886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512005,0.002673065,0.0000010746174,0.00055223674,0.000858847,0.00023887106,0.00011496898,0.000010144066,0.00043075622],"genre_scores_gemma":[0.9874283,0.011024971,0.00004275952,0.00006927601,0.00004625327,0.00004050293,0.000014459183,0.000012500957,0.0013209758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986838,0.00024239835,0.0005844884,0.00020928872,0.000046965906,0.00023306017],"domain_scores_gemma":[0.998816,0.0001930148,0.0005462661,0.00032686655,0.000092016635,0.000025795427],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00061014394,0.00015139472,0.0006078528,0.00006907893,0.000119095996,0.000010123179,0.00021837573,0.00023387713,0.0013778872],"category_scores_gemma":[0.00011916208,0.00011210927,0.000109776156,0.000034951154,0.00037839665,0.00015982873,0.000057810736,0.0001846313,0.000025517182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045824507,0.0002922812,0.8143923,0.000018590485,0.00072149263,0.0000014765656,0.0026957323,7.372268e-7,0.09558516,0.00031165633,0.00053887337,0.08085922],"study_design_scores_gemma":[0.0049174908,0.0005319373,0.9294412,0.00007614794,0.000009791564,0.0000051264824,0.00031040653,0.0000015649125,0.036047466,0.0003014842,0.028214764,0.00014262761],"about_ca_topic_score_codex":0.0009731248,"about_ca_topic_score_gemma":0.00003595237,"teacher_disagreement_score":0.115048856,"about_ca_system_score_codex":0.000028458207,"about_ca_system_score_gemma":0.00014372883,"threshold_uncertainty_score":0.99953496},"labels":[],"label_agreement":null},{"id":"W2592982225","doi":"10.2147/ott.s131611","title":"<em>GSTM1 </em>polymorphism is related to risks of nasopharyngeal cancer and laryngeal cancer: a meta-analysis","year":2017,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Funnel plot; Publication bias; Internal medicine; Odds ratio; Medicine; Confidence interval; Genotype; Subgroup analysis; Nasopharyngeal cancer; Oncology; Population; Gastroenterology; Nasopharyngeal carcinoma; Genetics; Biology; Gene","score_opus":0.10439801246588071,"score_gpt":0.37823501658510494,"score_spread":0.27383700411922424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592982225","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018117303,0.9773094,0.000015048233,0.0003390859,0.00028303533,0.00087984256,0.0028310034,0.000017648428,0.00020765523],"genre_scores_gemma":[0.010553278,0.984904,0.00013284295,0.00051898975,0.00025604406,0.0003735179,0.00043840395,0.000120952376,0.0027019652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966,0.00021169597,0.000963779,0.0012468888,0.00038285757,0.000594798],"domain_scores_gemma":[0.9977234,0.000045430195,0.0006448529,0.0010124001,0.00016754323,0.0004063494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044960933,0.00096549647,0.004020099,0.00029297872,0.00031676074,0.00011398631,0.000538357,0.0007922152,0.0007451602],"category_scores_gemma":[0.0000123448835,0.0007070565,0.0022848477,0.00031337852,0.00019262763,0.000016485074,0.00015124388,0.00035401384,0.0000067995397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002593526,0.00019582358,0.00013094768,0.0011228973,0.1352587,0.000046473357,0.00065440475,0.000010347069,0.0024033112,0.00011924179,0.0024240287,0.8573745],"study_design_scores_gemma":[0.0009207457,0.00046870127,0.00014450206,0.00021135648,0.053331405,0.000024227042,0.0000071126124,0.000008716209,0.0004908031,0.000042580115,0.94356054,0.0007892939],"about_ca_topic_score_codex":0.0011856343,"about_ca_topic_score_gemma":0.0011085405,"teacher_disagreement_score":0.94113654,"about_ca_system_score_codex":0.000030779975,"about_ca_system_score_gemma":0.00033524085,"threshold_uncertainty_score":0.99953806},"labels":[],"label_agreement":null},{"id":"W2593100475","doi":"10.2147/ott.s116136","title":"Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Medicine; Adenocarcinoma; CA19-9; Cohort; Pancreatic cancer; Pancreatic ductal adenocarcinoma; Oncology; Internal medicine; Radiology; Cancer","score_opus":0.01659291495249782,"score_gpt":0.2877013388438612,"score_spread":0.27110842389136336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593100475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996141,0.0008245721,0.000012159337,0.00031383173,0.00006766189,0.0011559116,0.00019678412,0.000011640485,0.0012764207],"genre_scores_gemma":[0.99745214,0.0010429743,0.00028066762,0.000041505864,0.000026261261,0.000058353857,0.00014788829,0.000015582098,0.0009346536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987455,0.000086191074,0.00031324153,0.00033061733,0.00028453598,0.00023993089],"domain_scores_gemma":[0.9989825,0.00016952028,0.00019494862,0.00036543724,0.00018675686,0.00010086714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041579318,0.00015907355,0.0006372043,0.00008917535,0.00023477347,0.000036106132,0.00007467356,0.000115451134,0.00002129369],"category_scores_gemma":[0.0002299147,0.00010339117,0.000028154993,0.00004652936,0.0001873127,0.00021530982,0.000045658722,0.00016917432,8.536398e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047790324,0.0005322958,0.9916722,0.00002576516,0.00030184607,0.000006749472,0.0016377226,7.234787e-8,0.00030895183,0.000059393977,0.000057827245,0.0006181203],"study_design_scores_gemma":[0.032264672,0.0028843707,0.9634389,0.00012335593,0.00009564063,0.0000010252226,0.00016158551,0.0003778174,0.0002772997,0.00022617487,0.000057164598,0.00009197443],"about_ca_topic_score_codex":0.0024391245,"about_ca_topic_score_gemma":0.00026102707,"teacher_disagreement_score":0.028233303,"about_ca_system_score_codex":0.00004908964,"about_ca_system_score_gemma":0.000105886174,"threshold_uncertainty_score":0.42161694},"labels":[],"label_agreement":null},{"id":"W2601936575","doi":"10.2147/ott.s127833","title":"Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"American Society for Radiation Oncology","keywords":"Cosmesis; Medicine; Breast cancer; Radiation therapy; Univariate analysis; Multivariate analysis; Nuclear medicine; Toxicity; Internal medicine; Oncology; Radiology; Surgery; Cancer","score_opus":0.01605708494908665,"score_gpt":0.26320694115313487,"score_spread":0.24714985620404822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601936575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993085,0.0007995831,0.00003182297,0.0043118657,0.0004265868,0.0005178,0.00007885359,0.0000053589315,0.0007430775],"genre_scores_gemma":[0.99732447,0.00059739075,0.00017146103,0.0012136177,0.0002633992,0.000113542475,0.000039994742,0.000015979509,0.00026017008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920803,0.000030392788,0.00012954076,0.00026465167,0.000085441614,0.00028191428],"domain_scores_gemma":[0.9994325,0.000013487269,0.00007732308,0.00031958355,0.000037959573,0.0001191232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013826972,0.00016783335,0.00017405383,0.000045922738,0.00048600402,0.00010087331,0.00019106524,0.0000845584,0.000014543315],"category_scores_gemma":[0.000012395397,0.00011674989,0.00004838355,0.000024762605,0.000089699184,0.000020399613,0.000035734138,0.000103843515,0.0000027957644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05671729,0.0002988897,0.6785682,0.0000044733983,0.0014399193,0.000031692332,0.0047995313,0.000496833,0.003950061,0.000050857336,0.0026777522,0.25096452],"study_design_scores_gemma":[0.023037925,0.000719014,0.6135003,0.000015850865,0.000013272255,0.000028531864,0.00026838516,0.00003171089,0.0007732151,0.000023617027,0.36132824,0.00025992354],"about_ca_topic_score_codex":0.36600792,"about_ca_topic_score_gemma":0.63632494,"teacher_disagreement_score":0.3586505,"about_ca_system_score_codex":0.00014872996,"about_ca_system_score_gemma":0.00022765897,"threshold_uncertainty_score":0.6382139},"labels":[],"label_agreement":null},{"id":"W2607856708","doi":"10.2147/ott.s121618","title":"No genetic relationship between <em>TLR2</em> rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Breast cancer; Medicine; Gene; Cancer; Oncology; Biology; Genetics; Internal medicine","score_opus":0.027574646184753974,"score_gpt":0.27573385777176,"score_spread":0.24815921158700605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607856708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95702547,0.040845383,0.00003589637,0.00091592746,0.00037054313,0.00035941607,0.00011081691,0.000034345187,0.00030220934],"genre_scores_gemma":[0.9887644,0.008402182,0.00022459753,0.00010054229,0.00016275978,0.00004720553,0.000102014055,0.000034285644,0.002162012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984743,0.00021105642,0.00042519826,0.0004209401,0.00006639919,0.00040209497],"domain_scores_gemma":[0.9990085,0.00013673225,0.00027583347,0.00043734116,0.000081687416,0.000059910108],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035192625,0.00028875854,0.00041870415,0.0001838112,0.0009923052,0.00013027989,0.00017485289,0.000343885,0.00024331971],"category_scores_gemma":[0.000057889367,0.0002538992,0.000058608395,0.000075336706,0.00026563034,0.00034123423,0.00009459031,0.000263131,0.00005156272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003719985,0.000058393663,0.81395674,0.000016640675,0.00012602865,0.000007438698,0.0012373668,0.0000048250095,0.12568113,0.0006644499,0.00020656969,0.057668433],"study_design_scores_gemma":[0.0024531533,0.0001433549,0.98121226,0.0000690252,0.00004003709,0.00006279675,0.00003417824,0.00002592181,0.0027275435,0.00076940743,0.012150332,0.0003120197],"about_ca_topic_score_codex":0.00047167856,"about_ca_topic_score_gemma":0.0004564639,"teacher_disagreement_score":0.1672555,"about_ca_system_score_codex":0.000040871186,"about_ca_system_score_gemma":0.00006569718,"threshold_uncertainty_score":0.9999913},"labels":[],"label_agreement":null},{"id":"W2611131904","doi":"10.2147/ott.s133563","title":"Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Queen's University","keywords":"Multicellular organism; Peptide; Chemistry; Computational biology; Biochemistry; Biology; Cell","score_opus":0.018628017103646914,"score_gpt":0.2953789955439952,"score_spread":0.2767509784403483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611131904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908444,0.007529712,0.00041768732,0.00009327606,0.000058672416,0.00037293043,0.00007869468,0.000009919531,0.00059465267],"genre_scores_gemma":[0.9933076,0.003201846,0.0028408796,0.0000313213,0.00009381503,0.000018724562,0.000059383336,0.000024026709,0.00042241265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989154,0.000060995648,0.00021122248,0.0003466027,0.00018143294,0.00028438037],"domain_scores_gemma":[0.9991369,0.000013799241,0.0001675242,0.00046694532,0.000120561825,0.00009426211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023638102,0.00018366639,0.00021463499,0.000027500166,0.00034678672,0.00008743265,0.00023542038,0.0001396465,0.000021727341],"category_scores_gemma":[0.000044827957,0.00015340927,0.00006539392,0.000026876362,0.00014968376,0.000019361141,0.00009425814,0.000086305445,0.0000017931326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019595954,0.00012516008,0.013530978,0.000032528966,0.00010243331,0.0000031324023,0.00014905579,0.000013580705,0.9647428,0.000018214541,0.00020569183,0.020880474],"study_design_scores_gemma":[0.0020498724,0.00071098417,0.006219049,0.000028491839,0.000015573403,0.000005927051,0.00009030785,0.0021488892,0.9244284,0.000095277035,0.06388976,0.00031745769],"about_ca_topic_score_codex":0.0006711463,"about_ca_topic_score_gemma":0.000049741044,"teacher_disagreement_score":0.06368406,"about_ca_system_score_codex":0.000012787742,"about_ca_system_score_gemma":0.000073415715,"threshold_uncertainty_score":0.62558484},"labels":[],"label_agreement":null},{"id":"W2612006186","doi":"10.2147/ott.s104177","title":"New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib","year":2017,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Afatinib; Medicine; Nivolumab; Lung cancer; Pembrolizumab; Ramucirumab; Oncology; Docetaxel; Context (archaeology); Squamous-cell carcinoma of the lung; Internal medicine; Chemotherapy; Cancer; Intensive care medicine; Immunotherapy; Epidermal growth factor receptor; Erlotinib","score_opus":0.05241281530813648,"score_gpt":0.4199899764586437,"score_spread":0.36757716115050726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612006186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006498618,0.9890403,0.000001460703,0.000155832,0.00022221294,0.0021120731,0.00006182765,0.000009681598,0.0077467514],"genre_scores_gemma":[0.0016595959,0.9945685,0.00033149103,0.00006104127,0.00015116588,0.00048749807,0.000082223465,0.000039377173,0.002619077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99885386,0.000051767063,0.0003664908,0.00032130623,0.00018913997,0.0002174575],"domain_scores_gemma":[0.9990187,0.000112448695,0.00034579006,0.00040742353,0.000027888706,0.000087697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059946953,0.00036634965,0.0011750371,0.000106927095,0.00011561805,0.00002364983,0.00012640946,0.00012111632,0.000053016232],"category_scores_gemma":[0.000003960512,0.00018221143,0.00021504928,0.000086704196,0.000028342309,0.00003374887,0.000006804004,0.00010786488,0.0000034414309],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077558136,0.00055479206,0.00040605987,0.0007144097,0.00026042433,0.00003388868,0.0014539531,4.978373e-7,5.6297733e-7,0.000042562802,0.00026300765,0.9961923],"study_design_scores_gemma":[0.0048226854,0.001321047,0.000698233,0.0025509337,0.00056547625,0.000006986198,0.000031220796,5.3940306e-7,0.000019485142,0.000030864256,0.98978734,0.00016516855],"about_ca_topic_score_codex":0.0007188202,"about_ca_topic_score_gemma":0.000119862285,"teacher_disagreement_score":0.9960271,"about_ca_system_score_codex":0.0002866948,"about_ca_system_score_gemma":0.0008675091,"threshold_uncertainty_score":0.7430366},"labels":[],"label_agreement":null},{"id":"W2616754233","doi":"10.2147/ott.s136484","title":"The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Alberta Children's Hospital Foundation; Children's Hospital Foundation","keywords":"Nelfinavir; Protease inhibitor (pharmacology); Refractory (planetary science); Medicine; Leukemia; Human immunodeficiency virus (HIV); Protease; Pharmacology; Virology; Immunology; Chemistry; Antiretroviral therapy; Biology; Enzyme; Viral load","score_opus":0.034973207282945014,"score_gpt":0.2994211456358922,"score_spread":0.2644479383529472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616754233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91438574,0.063703604,0.0006944466,0.010448989,0.00039532743,0.0064047207,0.000062311454,0.000059299833,0.0038455408],"genre_scores_gemma":[0.91698235,0.056558613,0.0017966239,0.00022679666,0.00069726387,0.0011519183,0.000041947602,0.00005587761,0.022488587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989073,0.000024454303,0.0002546014,0.00028376287,0.00022449461,0.00030533905],"domain_scores_gemma":[0.9986869,0.00021179466,0.00023917983,0.0006429216,0.00008617733,0.00013302894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002658395,0.0002556656,0.00032691102,0.00003909122,0.0010532427,0.0000832365,0.00017016771,0.000082300205,0.000013481004],"category_scores_gemma":[0.000034372628,0.00011007369,0.00017649333,0.000045935216,0.00018198918,0.0000693576,0.000019389798,0.000085923435,0.000006089205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008075578,0.0076845847,0.15051624,0.00017998776,0.002975182,0.000030279929,0.009894547,0.000006702002,0.0046721105,0.0030737845,0.005210854,0.80768013],"study_design_scores_gemma":[0.018909464,0.0030085766,0.04486304,0.000030292284,0.0004861358,0.000027388387,0.00047575662,0.00073754543,0.0040143495,0.00050029677,0.9266229,0.0003242439],"about_ca_topic_score_codex":0.000065214896,"about_ca_topic_score_gemma":0.0000040577784,"teacher_disagreement_score":0.92141205,"about_ca_system_score_codex":0.00013408407,"about_ca_system_score_gemma":0.0003877843,"threshold_uncertainty_score":0.8100798},"labels":[],"label_agreement":null},{"id":"W2646737791","doi":"10.2147/ott.s127317","title":"The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Meta-analysis; Prostate cancer; Prostatectomy; Hazard ratio; Internal medicine; Confidence interval; Oncology; Publication bias; MEDLINE; Urology; Cancer","score_opus":0.15697010279596987,"score_gpt":0.4731653371547831,"score_spread":0.31619523435881325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2646737791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044198206,0.99331534,9.0149996e-8,0.0008963417,0.000018530889,0.005116633,0.00016887522,0.0000070762526,0.000035143566],"genre_scores_gemma":[0.00014577208,0.99654955,0.000010536832,0.000116706084,0.000023300265,0.0006432327,0.00009549913,0.000025403486,0.002390016],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99774635,0.00042972574,0.0007976564,0.00040587172,0.0003611369,0.00025925715],"domain_scores_gemma":[0.99787885,0.0005207969,0.00092017616,0.00041181207,0.00013527063,0.00013310222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015901941,0.0003482377,0.0067236396,0.000105563435,0.0002079183,0.000117386735,0.000102239675,0.00015880508,0.000011321874],"category_scores_gemma":[0.00011322118,0.00012720891,0.0006169255,0.00016454543,0.000107956585,0.00006308847,0.000044413424,0.00035183685,0.0000011070854],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004918291,0.00008231294,0.5085822,0.14228407,0.25389993,0.000005394895,0.00004079624,2.0471032e-9,2.8495206e-10,0.000002023612,0.000032012013,0.09502209],"study_design_scores_gemma":[0.0022408518,0.0005652067,0.10025361,0.018359581,0.7564686,7.5746067e-7,0.0000042726456,2.800405e-7,8.682171e-9,0.000011594349,0.12185398,0.00024126728],"about_ca_topic_score_codex":0.00010952604,"about_ca_topic_score_gemma":0.00010996369,"teacher_disagreement_score":0.50256866,"about_ca_system_score_codex":0.00012674904,"about_ca_system_score_gemma":0.00016626326,"threshold_uncertainty_score":0.51874286},"labels":[],"label_agreement":null},{"id":"W2736563947","doi":"10.2147/ott.s142087","title":"Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Everolimus; Exploratory analysis; Medicine; Computer science; Medical physics; Oncology; Data science","score_opus":0.05140317221473301,"score_gpt":0.39460928105628057,"score_spread":0.34320610884154756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736563947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997542,0.0015195615,0.0000031272946,0.00026358018,0.000030861418,0.00023335678,0.000035605026,0.000013357697,0.00035854784],"genre_scores_gemma":[0.99388176,0.0058380254,0.00007513882,0.00004670008,0.000043092215,0.000009324399,0.0000042651413,0.000019558915,0.000082107064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990338,0.000076804325,0.00015487892,0.00023431865,0.00028077347,0.00021938955],"domain_scores_gemma":[0.9987174,0.000076102006,0.0002231577,0.00071493123,0.000098500386,0.00016987536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014307132,0.00015008418,0.0005786494,0.00028969336,0.00012135176,0.000024081866,0.000153669,0.000012484896,0.00013900171],"category_scores_gemma":[0.000057242334,0.000098370765,0.00021626106,0.00012785799,0.00023270107,0.00026479317,0.000024887588,0.00012349439,0.0000010409893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052069603,0.0013118387,0.6130756,0.0000387248,0.0033613539,0.00022986883,0.001126364,0.000017698518,0.18795791,0.00007299053,0.000051616596,0.18754905],"study_design_scores_gemma":[0.0022049963,0.004771047,0.9666635,0.000025658766,0.00010738997,0.000009465411,0.000070685215,0.00017692143,0.025075343,0.000109190136,0.00069191743,0.00009393196],"about_ca_topic_score_codex":0.00026309033,"about_ca_topic_score_gemma":0.00007120911,"teacher_disagreement_score":0.35358784,"about_ca_system_score_codex":0.00002273454,"about_ca_system_score_gemma":0.00008997904,"threshold_uncertainty_score":0.40114433},"labels":[],"label_agreement":null},{"id":"W2741932379","doi":"10.2147/ott.s133699","title":"A practical guide to the handling and administration of talimogene laherparepvec in Europe","year":2017,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Musculoskeletal synovial abnormalities and treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Rosetrees Trust; National Institute for Health and Care Research; Amgen","keywords":"Medicine; Oncolytic virus; Vial; Patient care; Herpes simplex virus; Internal medicine; Virus; Cancer; Virology; Nursing","score_opus":0.1262670155319251,"score_gpt":0.45647096414096927,"score_spread":0.3302039486090442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741932379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001956775,0.9937867,0.000008416679,0.00065808743,0.00008452934,0.00087795476,0.000028520742,0.0000059348827,0.002593102],"genre_scores_gemma":[0.0017001567,0.99664575,0.00038829405,0.000114005015,0.00016185953,0.000051760893,0.000042932315,0.000024204437,0.00087101513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998973,0.00008377496,0.00039771496,0.00024768926,0.00014115803,0.00015664157],"domain_scores_gemma":[0.9992259,0.00008444415,0.00022705364,0.00030014312,0.000058141686,0.00010429627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030278962,0.00021732596,0.0008834516,0.000053777538,0.00009027184,0.000041811632,0.00006185326,0.00010338086,0.000033561486],"category_scores_gemma":[0.00009814419,0.0001145931,0.00009852501,0.000079495694,0.00006170948,0.000047598325,0.00004678517,0.00014111053,0.000004680616],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119107885,0.00013913837,0.00027313293,0.0013164089,0.00019692018,0.000098908764,0.00009000268,1.8756827e-8,0.0000018032125,0.0002154212,0.00028487013,0.99726427],"study_design_scores_gemma":[0.00060714374,0.0006901013,0.0006519934,0.0022765177,0.00015973988,0.00016240447,0.000011781877,0.0000016159995,0.0000050946005,0.000009603196,0.9953169,0.00010705183],"about_ca_topic_score_codex":0.0002635109,"about_ca_topic_score_gemma":0.000114744595,"teacher_disagreement_score":0.9971572,"about_ca_system_score_codex":0.000019283787,"about_ca_system_score_gemma":0.0002265451,"threshold_uncertainty_score":0.4672971},"labels":[],"label_agreement":null},{"id":"W2750210114","doi":"10.2147/ott.s143315","title":"miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Natural Science Foundation of China","keywords":"Microvesicles; Mesenchymal stem cell; Cancer research; microRNA; Metastasis; Bone marrow; Cancer; Medicine; Transfection; Cancer cell; Exosome; Pathology; Immunology; Biology; Cell culture; Internal medicine","score_opus":0.01692403822953294,"score_gpt":0.2815639050798786,"score_spread":0.2646398668503457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750210114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806879,0.018511066,0.000035098674,0.00012815789,0.00014928047,0.00021073942,0.000083532206,0.0000057341476,0.00018847038],"genre_scores_gemma":[0.9937533,0.0050709997,0.00058753975,0.000027676648,0.0001656375,0.000024396757,0.000010439796,0.0000243976,0.00033560971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900395,0.000071880786,0.00018745908,0.00036789567,0.00013243286,0.00023637868],"domain_scores_gemma":[0.999124,0.00002025621,0.00025757574,0.00046329456,0.000045826557,0.00008907019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017237509,0.0001778692,0.00024679306,0.000036135363,0.00011987305,0.000041383595,0.00023326481,0.00011825509,0.000042342002],"category_scores_gemma":[0.000015125141,0.00015767601,0.000083432846,0.000035195226,0.0001312616,0.00001637176,0.00009928485,0.00010186854,0.0000011933716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001640091,0.00016273352,0.086038396,0.000017622178,0.000057637077,0.000015184416,0.000084552936,0.0000039584293,0.85380274,0.000007590337,0.00004568887,0.059599917],"study_design_scores_gemma":[0.0013838937,0.00017946768,0.057440188,0.00004190342,0.000012095773,0.0000020049938,0.000026494366,0.00012971107,0.9373574,0.00016055496,0.0030741226,0.00019211609],"about_ca_topic_score_codex":0.00055333367,"about_ca_topic_score_gemma":0.0001574277,"teacher_disagreement_score":0.08355474,"about_ca_system_score_codex":0.000018467152,"about_ca_system_score_gemma":0.00009705155,"threshold_uncertainty_score":0.64298415},"labels":[],"label_agreement":null},{"id":"W2769939168","doi":"10.2147/ott.s145776","title":"The relationship between <em>IGF2BP2</em> and <em>PPARG</em> polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Science Foundation of Fujian Province; Fujian Medical University; Jiangsu University; Centre in Green Chemistry and Catalysis","keywords":"Peroxisome proliferator-activated receptor gamma; Internal medicine; Medicine; Population; Genotyping; Esophageal squamous cell carcinoma; Oncology; Gastroenterology; Genotype; Biology; Genetics; Carcinoma; Gene; Peroxisome proliferator-activated receptor; Receptor; Environmental health","score_opus":0.023904805619880804,"score_gpt":0.2894256535990162,"score_spread":0.2655208479791354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769939168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98836535,0.008687807,0.00005922122,0.0010078006,0.00017963133,0.0011668849,0.000119582364,0.000026029276,0.0003876975],"genre_scores_gemma":[0.9971949,0.00049525447,0.00016690553,0.00018118789,0.0005881765,0.00007136593,0.00023407764,0.00008313224,0.0009850219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963333,0.0005031397,0.00061768375,0.0010703681,0.00063640455,0.000839111],"domain_scores_gemma":[0.9973981,0.0003597256,0.0003063401,0.0014399546,0.00013474228,0.00036115464],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0016375439,0.0005944025,0.00052525336,0.00014625394,0.0013783621,0.0007009405,0.00077284727,0.00043103815,0.000021787864],"category_scores_gemma":[0.0003767143,0.00039789092,0.00015811407,0.0001918908,0.0003586935,0.000080862796,0.0004126788,0.0004580885,0.000013664516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053550076,0.0001374762,0.9059647,0.000043950484,0.00004859224,0.000013963522,0.0017952836,0.000005308214,0.08543105,0.00020425618,0.00024553994,0.0055744164],"study_design_scores_gemma":[0.002420216,0.0009609548,0.98792475,0.000028722246,0.000023268844,0.0000161633,0.0001431904,0.0001864924,0.002739655,0.0013381462,0.00375102,0.0004673944],"about_ca_topic_score_codex":0.00034639623,"about_ca_topic_score_gemma":0.005512296,"teacher_disagreement_score":0.082691394,"about_ca_system_score_codex":0.0000598126,"about_ca_system_score_gemma":0.000086572094,"threshold_uncertainty_score":0.9999217},"labels":[],"label_agreement":null},{"id":"W2770086290","doi":"10.2147/ott.s151260","title":"Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Male Breast Health Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"Dalian Medical University","keywords":"Medicine; Occult; Breast cancer; Dermatomyositis; Prophylactic Mastectomy; Modified Radical Mastectomy; Mastectomy; Lymph node; Cancer; Immunohistochemistry; Dermatology; Pathology; Internal medicine","score_opus":0.015132958256609085,"score_gpt":0.32515894784137017,"score_spread":0.3100259895847611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770086290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7303487,0.24637595,0.0000011221202,0.020560116,0.000091807895,0.00092457264,0.00013218133,0.000010056182,0.001555505],"genre_scores_gemma":[0.775287,0.22000532,0.00023389411,0.0030264184,0.00012644254,0.000075981945,0.0000034924674,0.000015030705,0.0012264723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922836,0.00004196532,0.00021596215,0.00021041116,0.00015276801,0.00015055215],"domain_scores_gemma":[0.9988852,0.000027484492,0.00033090267,0.00041284593,0.0002467179,0.00009682327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018690208,0.00014833645,0.00040987763,0.000017658534,0.00037877288,0.000024956957,0.00005303914,0.000048576432,0.00006623957],"category_scores_gemma":[0.0000415086,0.00007147367,0.000043993707,0.000058343336,0.00023522158,0.00008574698,0.000040955638,0.00016015339,2.2009992e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011828234,0.00019317915,0.8771424,0.011052073,0.0006053036,0.028949216,0.0044715335,3.57646e-8,0.000092334645,0.00010775842,0.00727217,0.06893113],"study_design_scores_gemma":[0.0026703652,0.00013304513,0.6180364,0.015682912,0.00009704487,0.3509891,0.00011810086,0.0000038460353,0.00010271089,0.000028403063,0.012016114,0.00012195823],"about_ca_topic_score_codex":0.0007063847,"about_ca_topic_score_gemma":0.00015576054,"teacher_disagreement_score":0.32203987,"about_ca_system_score_codex":0.000017559894,"about_ca_system_score_gemma":0.00011767041,"threshold_uncertainty_score":0.29146117},"labels":[],"label_agreement":null},{"id":"W2775292267","doi":"10.2147/ott.s150092","title":"<em>Hopea odorata </em>extract inhibits hepatocellular carcinoma via induction of caspase-dependent apoptosis","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Bioactive natural compounds","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Propidium iodide; Apoptosis; IC50; Annexin; Cytotoxicity; Flow cytometry; Chemistry; Molecular biology; Pharmacology; Traditional medicine; Biochemistry; Biology; In vitro; Programmed cell death; Medicine","score_opus":0.019875542180613073,"score_gpt":0.25414810861660075,"score_spread":0.23427256643598768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775292267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885456,0.009573009,0.0001565556,0.00020110668,0.00045829336,0.00032821103,0.000059783408,0.000016189455,0.00066123065],"genre_scores_gemma":[0.9960357,0.0025456354,0.00031370248,0.00012312515,0.0004394467,0.000017899167,0.000121309764,0.000050289826,0.000352887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983594,0.00010011952,0.00031794113,0.00059759646,0.000286078,0.00033886582],"domain_scores_gemma":[0.9984153,0.000012363034,0.0003813996,0.0008147342,0.00022882632,0.00014740461],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003303388,0.00033545622,0.00035256907,0.00007155048,0.0003685811,0.000116729556,0.00037709277,0.00037752918,0.000043812757],"category_scores_gemma":[0.000036965885,0.00028612753,0.0001521049,0.00005536479,0.00017706196,0.000037804795,0.00018677302,0.00024060339,0.000007224799],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034966847,0.00016010858,0.013439409,0.000018799785,0.00013926395,0.000007614578,0.000117954885,0.0000011275077,0.96080285,0.00003219692,0.0004919981,0.024439022],"study_design_scores_gemma":[0.0015808825,0.00071803964,0.038638808,0.000019431835,0.00002763029,0.00003490503,0.00004675364,0.00009355029,0.9414789,0.00016286649,0.01681444,0.00038379862],"about_ca_topic_score_codex":0.00013531861,"about_ca_topic_score_gemma":0.0001476354,"teacher_disagreement_score":0.025199398,"about_ca_system_score_codex":0.000033810415,"about_ca_system_score_gemma":0.000068123816,"threshold_uncertainty_score":0.9999591},"labels":[],"label_agreement":null},{"id":"W2782520798","doi":"10.2147/ott.s114276","title":"miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Yang-Ming University; Beef Cattle Research Council; National Science Council","keywords":"Suppressor; Apoptosis; PI3K/AKT/mTOR pathway; Cancer research; Urothelial carcinoma; Human bladder; Urinary bladder; Medicine; Urology; Chemistry; Internal medicine; Bladder cancer; Cancer; Biochemistry","score_opus":0.012346080907464302,"score_gpt":0.2756773129436678,"score_spread":0.2633312320362035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782520798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604315,0.002301092,0.000037356545,0.00020212571,0.00040593522,0.0003892536,0.000022738155,0.000017394821,0.0005809291],"genre_scores_gemma":[0.9967116,0.00025042865,0.0006530783,0.00097119645,0.0010457569,0.00006266829,0.000021708414,0.000054708413,0.00022885503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834466,0.000102274535,0.00027829246,0.00065198157,0.00016374166,0.00045905847],"domain_scores_gemma":[0.9993257,0.000023337661,0.000103123566,0.00028139877,0.000077899655,0.00018855995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002518825,0.00030316508,0.00028624362,0.00007605063,0.0002032309,0.000060498714,0.00020820517,0.00015610899,0.00013016394],"category_scores_gemma":[0.000021784963,0.0002731675,0.000059894533,0.00009002613,0.00013266188,0.000014574331,0.000115398136,0.00013031236,0.00001174885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032036466,0.00022648646,0.0012255041,0.00001457868,0.00005073647,0.000008917326,0.00061361946,8.2839216e-7,0.9956265,0.000008264924,0.00082742714,0.0010767446],"study_design_scores_gemma":[0.0021390815,0.0021616148,0.0019462291,0.000023916073,0.00000860957,0.00000974183,0.0000660784,0.000014658387,0.9473938,0.00008027572,0.04579404,0.0003619633],"about_ca_topic_score_codex":0.0002391693,"about_ca_topic_score_gemma":0.000032724292,"teacher_disagreement_score":0.048232738,"about_ca_system_score_codex":0.000022647966,"about_ca_system_score_gemma":0.00006886024,"threshold_uncertainty_score":0.99997205},"labels":[],"label_agreement":null},{"id":"W2783139321","doi":"10.2147/ott.s155511","title":"Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Associated Medical Services","funders":"Thailand Research Fund; Khon Kaen University","keywords":"Cell growth; Motility; PI3K/AKT/mTOR pathway; Annexin; Cyclin D1; Vimentin; Apoptosis; Protein kinase B; Cancer research; Gene knockdown; Cell cycle; Biology; Cell biology; Signal transduction; Chemistry; Immunology; Immunohistochemistry; Biochemistry","score_opus":0.02006550453381741,"score_gpt":0.2687902656443901,"score_spread":0.2487247611105727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783139321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075437,0.003933367,0.00009756118,0.0035624406,0.00006616312,0.0009361581,0.0000061180804,0.000048888713,0.0005949175],"genre_scores_gemma":[0.99621814,0.001468698,0.00045147943,0.0007780928,0.00044650582,0.00006482413,0.000016655093,0.000025526606,0.00053005194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987192,0.000101055186,0.00020969614,0.00035590157,0.00028291455,0.00033120523],"domain_scores_gemma":[0.99922657,0.00003770534,0.000051867086,0.0003213509,0.00018170918,0.00018079019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039793405,0.0001835839,0.00023841529,0.000042646272,0.00033486093,0.00009161948,0.0000939813,0.00009919198,0.00018332884],"category_scores_gemma":[0.00001597891,0.000099233126,0.00005314144,0.00013845184,0.00035770217,0.0001082359,0.000052020623,0.00020492858,0.000019471967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010475464,0.00075072696,0.50099754,0.000108752734,0.00017096651,0.000006415186,0.0044752727,6.0311197e-7,0.22921951,0.00016864458,0.0012583622,0.2617957],"study_design_scores_gemma":[0.002925891,0.001992225,0.9090826,0.00003405072,0.000018464658,0.00002356383,0.00005162853,0.0021187838,0.06292104,0.001151432,0.019491328,0.0001889758],"about_ca_topic_score_codex":0.00015115009,"about_ca_topic_score_gemma":0.000010439829,"teacher_disagreement_score":0.4080851,"about_ca_system_score_codex":0.000024034416,"about_ca_system_score_gemma":0.00004835606,"threshold_uncertainty_score":0.40466094},"labels":[],"label_agreement":null},{"id":"W2783821295","doi":"10.2147/ott.s153682","title":"Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Second Military Medical University; Natural Science Foundation of Fujian Province","keywords":"Pooled analysis; Medicine; Oncology; Internal medicine; Cancer research; Meta-analysis","score_opus":0.008153278812322048,"score_gpt":0.2903859823246057,"score_spread":0.2822327035122837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783821295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823594,0.0010070093,0.000024072824,0.000012724885,0.00000783292,0.0002449776,0.000025651563,0.00000210304,0.0004396967],"genre_scores_gemma":[0.9993425,0.0003219166,0.00015868623,0.000024949624,0.00003630444,0.00001752425,0.00005327406,0.000010371832,0.000034470486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914,0.00007461588,0.00023436145,0.00021576096,0.00015859609,0.00017661351],"domain_scores_gemma":[0.99947864,0.000012766008,0.00008008649,0.00021609946,0.0001585773,0.000053811516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015699877,0.00009306525,0.00024062775,0.00014678571,0.000027036493,0.0000055549717,0.00010711589,0.000084058076,0.000059351776],"category_scores_gemma":[0.00006910073,0.00007325968,0.00006509518,0.00024745872,0.000098561286,0.0000038971452,0.00006891799,0.00004819128,7.9990247e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025057126,0.00023869885,0.24363747,0.000009936509,0.00017532887,3.3719365e-7,0.00015579932,0.000004894515,0.74800235,0.000008758974,0.000015569327,0.007500267],"study_design_scores_gemma":[0.0008864001,0.0012566589,0.2740504,0.000057992213,0.00001973006,1.7771812e-7,0.00003289668,0.00048161251,0.72199017,0.00009799657,0.0010373743,0.000088573026],"about_ca_topic_score_codex":0.00015184266,"about_ca_topic_score_gemma":0.00004399659,"teacher_disagreement_score":0.03041293,"about_ca_system_score_codex":0.000006315928,"about_ca_system_score_gemma":0.000047945956,"threshold_uncertainty_score":0.29874432},"labels":[],"label_agreement":null},{"id":"W2790826021","doi":"10.2147/ott.s155160","title":"Prognostic significance of epidermal growth factor receptor expression in glioma patients","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Department of Science and Technology of Sichuan Province","keywords":"Epidermal growth factor receptor; Glioma; Epidermal growth factor; Expression (computer science); Medicine; Oncology; Cancer research; Factor (programming language); Internal medicine; Receptor; Computer science","score_opus":0.01804743681803861,"score_gpt":0.2716772698489575,"score_spread":0.2536298330309189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790826021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779785,0.0010368425,0.000005010851,0.00026627572,0.00011916439,0.0005325664,0.000020649923,0.000013579487,0.00020809156],"genre_scores_gemma":[0.9983929,0.000593357,0.0007306025,0.00009854262,0.00008421889,0.000051055238,0.000017535513,0.000014953384,0.00001682824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919796,0.000038162056,0.00021497642,0.00021469401,0.00015701997,0.00017718071],"domain_scores_gemma":[0.99950796,0.00007202945,0.00008628578,0.00012340014,0.000119094126,0.00009124431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054102504,0.00012872057,0.0002635372,0.000090000714,0.00003881037,0.0000069208686,0.00003737661,0.000057304795,0.00021263504],"category_scores_gemma":[0.0000468806,0.00007688463,0.000043095257,0.00012603571,0.000083580664,0.000059539936,0.000014558928,0.000049928505,0.000009949222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033982034,0.0011449548,0.8734587,0.000023157529,0.00002688873,0.000012361675,0.00047312575,2.8154455e-8,0.09863466,0.000016139618,0.0003270638,0.025543137],"study_design_scores_gemma":[0.0031849372,0.0013449537,0.66730267,0.00012121749,0.0000058174646,0.0000015031661,0.000016602831,0.000005262587,0.32581085,0.00008053295,0.0020545584,0.00007109278],"about_ca_topic_score_codex":0.000059233396,"about_ca_topic_score_gemma":0.000005821045,"teacher_disagreement_score":0.22717619,"about_ca_system_score_codex":0.000022714967,"about_ca_system_score_gemma":0.000024117908,"threshold_uncertainty_score":0.31352642},"labels":[],"label_agreement":null},{"id":"W2793187279","doi":"10.2147/ott.s148363","title":"Response to crizotinib in a non-small-cell lung cancer patient harboring an <em>EML4-ALK</em> fusion with an atypical <em>LTBP1</em> insertion","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Crizotinib; Anaplastic lymphoma kinase; Lung cancer; Fusion gene; Cancer research; KRAS; Medicine; Cancer; Biology; Oncology; Internal medicine; Gene; Genetics","score_opus":0.01388789291140281,"score_gpt":0.2961615911127861,"score_spread":0.2822736982013833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793187279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904993,0.0041075144,0.00030248964,0.001087141,0.0007227076,0.0023024506,0.00009874561,0.00016301619,0.00071661104],"genre_scores_gemma":[0.9900305,0.00198826,0.0032776447,0.002117916,0.00075363606,0.00055357313,0.00016351383,0.000173956,0.0009409489],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99581146,0.00032812782,0.0007920145,0.001263941,0.0008126782,0.0009917947],"domain_scores_gemma":[0.99732655,0.000114400296,0.00030294224,0.00088734605,0.00052214466,0.0008466295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064556487,0.00074534654,0.00086259167,0.00047868522,0.0005596593,0.00020305016,0.00025452577,0.0003258828,0.00046059623],"category_scores_gemma":[0.000047855374,0.00056355883,0.00014881798,0.0006950607,0.00012933262,0.00051257154,0.000094507144,0.00038261493,0.000034010096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.079131745,0.007657273,0.06758908,0.00030141443,0.00095003255,0.0006230438,0.08637751,0.00024093334,0.48374245,0.00034419366,0.003137091,0.26990524],"study_design_scores_gemma":[0.035442356,0.033623308,0.6997761,0.002215298,0.00071327516,0.000091228234,0.002848588,0.005376751,0.021719238,0.00018552151,0.19574647,0.0022618426],"about_ca_topic_score_codex":0.00049839634,"about_ca_topic_score_gemma":0.007962495,"teacher_disagreement_score":0.63218707,"about_ca_system_score_codex":0.00067556807,"about_ca_system_score_gemma":0.00062276045,"threshold_uncertainty_score":0.9996816},"labels":[],"label_agreement":null},{"id":"W2794323096","doi":"10.2147/ott.s158171","title":"Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Science and Technology Department of Zhejiang Province; Department of Education of Zhejiang Province","keywords":"Medicine; Meta-analysis; Neuroendocrine tumors; Systematic review; Randomized controlled trial; Primary tumor; Internal medicine; Odds ratio; MEDLINE; Oncology; Surgery; Cancer; Metastasis","score_opus":0.04080444151786777,"score_gpt":0.33365198101943877,"score_spread":0.292847539501571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794323096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020635126,0.9912684,5.9397826e-7,0.0000515043,0.000007903095,0.006393334,0.00017436116,0.000007001905,0.00003341478],"genre_scores_gemma":[0.0019485881,0.9968604,0.00008658127,0.00013166555,0.0000070623073,0.00060190214,0.000048526468,0.00004744787,0.00026786188],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963824,0.0010667775,0.0009987082,0.0005068602,0.0007468042,0.00029841167],"domain_scores_gemma":[0.99732393,0.00043776384,0.0010587047,0.0007502182,0.00027489336,0.00015449582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031674086,0.00044918884,0.006439393,0.0003529246,0.000051746327,0.0000159129,0.00021536606,0.000006320027,0.000097777185],"category_scores_gemma":[0.00030881143,0.00019940599,0.0007755197,0.0012102998,0.0002440273,0.000102642574,0.00011250687,0.00028252244,8.5666585e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038989226,0.000483226,0.0026595155,0.9449943,0.050807104,0.00012969873,0.000023590115,4.061021e-7,7.753588e-7,0.000013569593,0.000020703554,0.00047724662],"study_design_scores_gemma":[0.0021994344,0.0030100034,0.008344376,0.093082815,0.8830764,0.000093676455,0.00001692809,0.000012566899,0.000012830457,0.000075031494,0.009660746,0.00041514935],"about_ca_topic_score_codex":0.00009336322,"about_ca_topic_score_gemma":0.000057843867,"teacher_disagreement_score":0.8519115,"about_ca_system_score_codex":0.00005320314,"about_ca_system_score_gemma":0.00018398005,"threshold_uncertainty_score":0.81315404},"labels":[],"label_agreement":null},{"id":"W2796235852","doi":"10.2147/ott.s152140","title":"Association between WWOX and the risk of malignant tumor, especially among Asians: evidence from a meta-analysis","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Publication bias; Meta-analysis; Odds ratio; Funnel plot; WWOX; Medicine; Internal medicine; Oncology; Case-control study; Genetic model; Cancer; Genetics; Gene; Biology; Suppressor","score_opus":0.023198661660829182,"score_gpt":0.25517973883306566,"score_spread":0.23198107717223648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796235852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98508364,0.013859878,0.00021989428,0.0003856005,0.000030290132,0.00015515531,0.00006582856,0.0000026219445,0.00019708865],"genre_scores_gemma":[0.98289585,0.016193042,0.0003944364,0.00018774201,0.000057229903,0.000012407538,0.000019147885,0.000009377586,0.00023074968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990545,0.00017940688,0.00021002439,0.00028159676,0.0001472235,0.00012724788],"domain_scores_gemma":[0.9993747,0.0000786477,0.00023153519,0.0001957983,0.0000779478,0.00004139027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004542003,0.00012812646,0.00035716215,0.000029050574,0.00011367546,0.000033648255,0.000112293885,0.00006169939,0.000064738095],"category_scores_gemma":[0.00006279778,0.0000767813,0.00022694777,0.00010103643,0.00017673189,0.0000046350588,0.000057579808,0.000049343507,0.0000010059752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002925969,0.00004711774,0.87780535,0.0000043108835,0.065840505,8.1431983e-7,0.00096768764,0.0000061913775,0.05091002,0.00002985426,0.00038824693,0.0037072818],"study_design_scores_gemma":[0.00081901986,0.00024045446,0.948039,0.0000029662638,0.010784862,2.0682938e-7,0.00006150681,0.00003372751,0.035145592,0.000910291,0.00381412,0.00014827364],"about_ca_topic_score_codex":0.0004435215,"about_ca_topic_score_gemma":0.0005119297,"teacher_disagreement_score":0.070233606,"about_ca_system_score_codex":0.000004019666,"about_ca_system_score_gemma":0.000020798541,"threshold_uncertainty_score":0.31310505},"labels":[],"label_agreement":null},{"id":"W2801288479","doi":"10.2147/ott.s151751","title":"Role of Beclin1 expression in patients with hepatocellular carcinoma: a meta-analysis","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Capital Foundation of Medical Development","keywords":"Hepatocellular carcinoma; Medicine; Meta-analysis; Internal medicine; Cirrhosis; Hazard ratio; Oncology; Confidence interval; Odds ratio; Cochrane Library; Biomarker; Stage (stratigraphy); Gastroenterology; Biology","score_opus":0.020521972521979383,"score_gpt":0.2598492306203965,"score_spread":0.23932725809841712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801288479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98749655,0.011683975,0.000028388537,0.000048504724,0.000011624614,0.00030285877,0.000014884784,0.000011754434,0.00040146778],"genre_scores_gemma":[0.9989314,0.00020548167,0.00043375226,0.00023384509,0.000039131486,0.00002047706,0.000030056373,0.00001669984,0.00008913794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990812,0.000047394366,0.00022831943,0.0002484677,0.00023427751,0.00016036052],"domain_scores_gemma":[0.9993557,0.000020034024,0.000107276894,0.00030103643,0.00011873598,0.00009726845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115562056,0.00015374727,0.0006909426,0.00016040825,0.000043137046,0.0000062482163,0.00005593436,0.00006148605,0.00068944227],"category_scores_gemma":[0.0000030578958,0.00008924586,0.00024979073,0.00028870584,0.0000996582,0.000058061323,0.000013839229,0.00006875541,0.0000028408049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013924844,0.00067002093,0.98112524,0.00000816866,0.01092481,0.000007378309,0.00068963954,7.0172507e-7,0.003910402,0.000034494242,0.000014539905,0.0012221121],"study_design_scores_gemma":[0.0044879443,0.001482021,0.9384807,0.000007864678,0.008967866,5.2441646e-7,0.000056161767,0.0002359739,0.044251006,0.00034997432,0.0015360162,0.00014395373],"about_ca_topic_score_codex":0.00009577331,"about_ca_topic_score_gemma":0.000010780578,"teacher_disagreement_score":0.042644557,"about_ca_system_score_codex":0.000010041048,"about_ca_system_score_gemma":0.000032341755,"threshold_uncertainty_score":0.7548909},"labels":[],"label_agreement":null},{"id":"W2804093461","doi":"10.2147/ott.s165209","title":"A large and aggressive fibromatosis in the axilla: a rare case report and review of the literature","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Jilin University","keywords":"Axilla; Aggressive fibromatosis; Fibromatosis; Pathological; Medicine; Radiology; Positron emission tomography; Computed tomography; Pathology; Internal medicine","score_opus":0.01284677504363748,"score_gpt":0.2984318396175701,"score_spread":0.2855850645739326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804093461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.602762,0.39308584,1.9094803e-7,0.0034987999,0.00003550157,0.00035548094,0.000015083308,0.000005311903,0.00024180379],"genre_scores_gemma":[0.8438513,0.15349951,0.00007498148,0.0023343523,0.00009895462,0.000024829893,0.0000036980548,0.000010057472,0.00010226264],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9992446,0.00008323353,0.00020733106,0.00019468283,0.00013573284,0.00013445476],"domain_scores_gemma":[0.99932325,0.00008675821,0.00016577143,0.000284674,0.00010114005,0.000038408914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035816638,0.00013073819,0.00032726018,0.000028997662,0.00013908588,0.000015679036,0.000037120586,0.0000404149,0.000021305374],"category_scores_gemma":[0.00019428544,0.0000586191,0.00004279128,0.0001993858,0.00021353694,0.000037780603,0.000051355983,0.00012023625,3.1981895e-7],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010170974,0.0007220868,0.42086074,0.013979544,0.00089944137,0.30150065,0.15992147,5.953552e-9,0.0016102989,0.0016641523,0.034713294,0.06311123],"study_design_scores_gemma":[0.0056962785,0.0015630967,0.16242474,0.03345061,0.00022361279,0.58915925,0.0039631985,0.000009127034,0.000811933,0.0010513752,0.20126641,0.00038037883],"about_ca_topic_score_codex":0.00003933714,"about_ca_topic_score_gemma":0.000040193885,"teacher_disagreement_score":0.2876586,"about_ca_system_score_codex":0.0000062739077,"about_ca_system_score_gemma":0.000022684511,"threshold_uncertainty_score":0.23904176},"labels":[],"label_agreement":null},{"id":"W2883816907","doi":"10.2147/ott.s166399","title":"Outcome of eribulin as a late treatment line for Thai metastatic breast cancer patients","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Emergency Physicians","funders":"","keywords":"Eribulin; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Radiomics; Cancer; Radiology","score_opus":0.04725875636328954,"score_gpt":0.3979276726502522,"score_spread":0.3506689162869627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883816907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453574,0.0024004467,0.000011136983,0.0014181259,0.0002633056,0.00072225835,0.00033442982,0.000014823257,0.00029974993],"genre_scores_gemma":[0.9921308,0.003767423,0.000372239,0.0008689519,0.00024927585,0.00014522429,0.00005945812,0.000019872077,0.0023867537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999375,0.000015723052,0.00019661659,0.00017107098,0.00007515637,0.0001664238],"domain_scores_gemma":[0.9995851,0.000038511236,0.00008469718,0.00009095223,0.00011291605,0.00008783846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039159568,0.00014365799,0.00035905375,0.000041919797,0.00005281958,0.0000045200345,0.000025668829,0.000031471267,0.00088803953],"category_scores_gemma":[0.000002452863,0.00008942097,0.000088479894,0.000052846444,0.00007526821,0.000028902503,0.0000067195997,0.000026744361,0.0000065144354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011665721,0.004645399,0.7086776,0.00010368082,0.002226837,0.000012041842,0.0026325856,0.0000020336292,0.010818499,0.00013351791,0.0011982733,0.25788385],"study_design_scores_gemma":[0.094009005,0.055274546,0.45355564,0.000132053,0.0014745807,0.000036164118,0.00008223192,0.0005501282,0.052355114,0.0013120392,0.34064934,0.00056913943],"about_ca_topic_score_codex":0.0005794236,"about_ca_topic_score_gemma":0.00010411682,"teacher_disagreement_score":0.33945107,"about_ca_system_score_codex":0.000059745937,"about_ca_system_score_gemma":0.000057891393,"threshold_uncertainty_score":0.972341},"labels":[],"label_agreement":null},{"id":"W2888206604","doi":"10.2147/ott.s167355","title":"Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysis","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Meta-analysis; Cancer; Biomarker; Biology","score_opus":0.04808960426515019,"score_gpt":0.3356476239631523,"score_spread":0.2875580196980021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888206604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797375,0.019661082,0.00018923204,0.000048520298,0.00005720235,0.0002004203,0.000041569303,0.00000400401,0.00006043325],"genre_scores_gemma":[0.99600285,0.00275005,0.00076612283,0.00023056353,0.00008955315,0.000087680484,0.000015964586,0.000010397788,0.00004682763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904585,0.00010457098,0.00023854303,0.0003616465,0.000100622,0.00014876566],"domain_scores_gemma":[0.99951845,0.000033778306,0.00012958208,0.00016547162,0.000102135244,0.000050603907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022539859,0.00013087432,0.00037692545,0.00004666755,0.000036915364,0.000009932209,0.00008424343,0.00010919749,0.00012775877],"category_scores_gemma":[0.000043582088,0.00008914447,0.00013263291,0.00012250975,0.00018263125,0.0000043998702,0.000041636085,0.000055464814,4.117119e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037818472,0.00030696284,0.65303844,0.000013620912,0.0021202422,0.0000015221271,0.0002144247,0.000013541217,0.33911332,0.000007745921,0.00016141057,0.004630558],"study_design_scores_gemma":[0.0026856514,0.004784002,0.4875999,0.000023420664,0.004820407,0.0000012342089,0.00004515886,0.00013368258,0.48055524,0.00029130414,0.018493144,0.00056684716],"about_ca_topic_score_codex":0.000041704592,"about_ca_topic_score_gemma":0.000071508206,"teacher_disagreement_score":0.16543855,"about_ca_system_score_codex":0.000005798595,"about_ca_system_score_gemma":0.000028592782,"threshold_uncertainty_score":0.3635206},"labels":[],"label_agreement":null},{"id":"W2891165291","doi":"10.2147/ott.s155438","title":"Evaluation of supportive and barrier-protective skin care products in the daily prevention and treatment of cutaneous toxicity during systemic chemotherapy","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Montreal General Hospital; Montreal Children's Hospital","funders":"","keywords":"Medicine; Erythema; Tolerability; Casual; Dermatology; Summary of Product Characteristics; Skin care; Discontinuation; Skin cancer; Observational study; Adverse effect; Desquamation; Internal medicine; Cancer; Pharmacology; Drug; Nursing","score_opus":0.020584876058098344,"score_gpt":0.29389508986183394,"score_spread":0.2733102138037356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891165291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98752207,0.009914838,0.000011670399,0.00017395295,0.000033095435,0.002142583,0.000012727297,0.000010261205,0.00017880424],"genre_scores_gemma":[0.99532217,0.0042983824,0.00015283727,0.000029501714,0.000087626024,0.00005611191,0.000005778285,0.000018873116,0.000028738303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986304,0.00023813907,0.00030198673,0.00032321998,0.00035717196,0.00014907158],"domain_scores_gemma":[0.9990996,0.000045462595,0.00021325087,0.00023358014,0.0003655858,0.000042493306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005431235,0.00018122963,0.00038078052,0.00009059211,0.00007511491,0.000009453397,0.000039055183,0.00010767452,0.000032120635],"category_scores_gemma":[0.000042335338,0.000118419666,0.000042367785,0.0001517257,0.00021806403,0.00006087627,0.00000817138,0.000080225305,2.0388082e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026576743,0.00065509154,0.033168763,0.0002593982,0.00044329744,0.000011261308,0.10077515,0.0000027565986,0.62742335,0.000019187391,0.0000044406543,0.23457962],"study_design_scores_gemma":[0.010499082,0.005478478,0.14901264,0.00032617195,0.00015157327,0.00030082153,0.004247171,0.00020853132,0.82899266,0.0005406659,0.000079459554,0.00016275619],"about_ca_topic_score_codex":0.00015757309,"about_ca_topic_score_gemma":0.00009622539,"teacher_disagreement_score":0.23441686,"about_ca_system_score_codex":0.00014852302,"about_ca_system_score_gemma":0.00012637439,"threshold_uncertainty_score":0.48290136},"labels":[],"label_agreement":null},{"id":"W2896789425","doi":"10.2147/ott.s167872","title":"Down-regulation of CXCL 11 inhibits colorectal cancer cell growth and epithelial-mesenchymal transition","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Epithelial–mesenchymal transition; Colorectal cancer; Mesenchymal stem cell; Transition (genetics); Cancer research; Cell growth; Medicine; Oncology; Cancer; Chemistry; Internal medicine; Pathology; Metastasis; Gene; Biochemistry","score_opus":0.009312997384674244,"score_gpt":0.24903343032281497,"score_spread":0.23972043293814072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896789425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954061,0.002912585,0.00008452254,0.00043146583,0.000100035424,0.00019453935,0.000019334539,0.000015835849,0.0008355802],"genre_scores_gemma":[0.99544936,0.003610242,0.00027868504,0.00013790421,0.00042900626,0.0000063305824,0.000016565857,0.000014272858,0.000057651887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940383,0.000018585766,0.00016125558,0.0001683197,0.00012357494,0.00012440883],"domain_scores_gemma":[0.99969935,0.000021018808,0.00006307681,0.00004971202,0.000093500894,0.00007333951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009418113,0.00010966846,0.00022086028,0.00003509818,0.00006931183,0.000008992093,0.000016320637,0.00007664934,0.00034472966],"category_scores_gemma":[0.000003367456,0.00008208548,0.000041885698,0.000069237474,0.00011193444,0.000074563424,0.0000062802565,0.0000496915,7.325126e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036449565,0.00008948535,0.012015953,0.00005336508,0.000026064636,7.7262393e-7,0.0021118494,5.115827e-7,0.9731204,0.00008788701,0.000076042124,0.012053164],"study_design_scores_gemma":[0.002449653,0.0007030153,0.038224492,0.000077425706,0.000027917447,0.000010295327,0.00009164009,0.00043355196,0.9560345,0.00021245822,0.0016288038,0.00010624064],"about_ca_topic_score_codex":0.0005610601,"about_ca_topic_score_gemma":0.00006835125,"teacher_disagreement_score":0.02620854,"about_ca_system_score_codex":0.000015697846,"about_ca_system_score_gemma":0.000034557954,"threshold_uncertainty_score":0.3774548},"labels":[],"label_agreement":null},{"id":"W2897385169","doi":"10.2147/ott.s184898","title":"Novel EXO-T vaccine using polyclonal CD4<sup>+</sup> T cells armed with HER2-specific exosomes for HER2-positive breast cancer","year":2018,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Microvesicles; Polyclonal antibodies; Breast cancer; Medicine; Trastuzumab; Cancer research; Virology; Cancer; Immunology; Antibody; Chemistry; Internal medicine; microRNA; Biochemistry","score_opus":0.05716456505432307,"score_gpt":0.35005826712262816,"score_spread":0.2928937020683051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897385169","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044548507,0.9861975,0.000353317,0.0004991621,0.0005533508,0.005276636,0.0018828326,0.00010488161,0.0006774706],"genre_scores_gemma":[0.00014689114,0.9826492,0.003121238,0.00040158402,0.004258353,0.0005717891,0.00048776125,0.00055064686,0.007812528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99426425,0.00023282669,0.0011013084,0.0017611579,0.0011174792,0.001522997],"domain_scores_gemma":[0.9963477,0.0004983228,0.0006279718,0.0010411723,0.00075052486,0.0007342869],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007549826,0.0015328744,0.0038080565,0.00056116044,0.00047941817,0.00022664173,0.000501229,0.00074211846,0.0046196333],"category_scores_gemma":[0.000010424733,0.0010452477,0.00092680665,0.0007481132,0.00043685385,0.00020301725,0.00012935801,0.00090081326,0.00003281578],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005901874,0.0012774601,0.00010937517,0.004655324,0.0036754417,0.00014781546,0.00067755335,0.000004040305,0.014386445,0.00008562876,0.005281485,0.96379757],"study_design_scores_gemma":[0.0078043235,0.0019454749,0.00021033322,0.009913965,0.0006663888,0.001173885,0.000052121923,0.00011929749,0.0005384133,0.000024572251,0.97634965,0.0012015607],"about_ca_topic_score_codex":0.00029902803,"about_ca_topic_score_gemma":0.00011456223,"teacher_disagreement_score":0.9710682,"about_ca_system_score_codex":0.0007555957,"about_ca_system_score_gemma":0.0013474089,"threshold_uncertainty_score":0.999742},"labels":[],"label_agreement":null},{"id":"W2900767667","doi":"10.2147/ott.s168478","title":"Potential role of Toll-like receptor 2 expression and polymorphisms in colon cancer susceptibility in the Saudi Arabian population","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Deanship of Scientific Research, King Saud University; King Saud University","keywords":"Colorectal cancer; Toll-like receptor; Toll; Medicine; Oncology; Cancer research; Receptor; Internal medicine; Traditional medicine; Genetics; Cancer; Bioinformatics; Immunology; Biology; Innate immune system","score_opus":0.007153032326777952,"score_gpt":0.2460535840700643,"score_spread":0.23890055174328637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900767667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98893195,0.010201027,0.000003768742,0.00033630346,0.00020557325,0.00022875595,0.0000048952365,0.0000058651467,0.00008184128],"genre_scores_gemma":[0.997377,0.0023353873,0.000019004936,0.00008697026,0.00003541499,0.000016924336,0.00003279104,0.0000051215998,0.00009138764],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991753,0.0002822263,0.00021618624,0.00015515041,0.000029540966,0.00014156234],"domain_scores_gemma":[0.9997165,0.0000392456,0.0000901218,0.00012297183,0.00002426529,0.0000068618074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003695156,0.00008791508,0.00015954438,0.00006992272,0.00009217822,0.000008141887,0.00006428597,0.00013333761,0.00027612594],"category_scores_gemma":[0.0000102124295,0.000058791007,0.000022020335,0.00007202578,0.00012922833,0.00009688392,0.000018208746,0.000103724014,0.0000037544353],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010707057,0.000067899346,0.07937678,0.0000029424925,0.000008962159,3.49736e-7,0.002361219,0.000001072043,0.8836474,0.0000598324,0.000083986146,0.03331886],"study_design_scores_gemma":[0.0019562962,0.0004275685,0.741873,0.000056754732,0.000004208255,0.0000058978408,0.00043049216,0.000026334525,0.24211426,0.0006060575,0.012388446,0.000110678644],"about_ca_topic_score_codex":0.0017488106,"about_ca_topic_score_gemma":0.0007706474,"teacher_disagreement_score":0.6624962,"about_ca_system_score_codex":0.00001812694,"about_ca_system_score_gemma":0.000017738039,"threshold_uncertainty_score":0.30233854},"labels":[],"label_agreement":null},{"id":"W2913788535","doi":"10.2147/ott.s191478","title":"<p>Potent in vitro and xenograft antitumor activity of a novel agent, PV-10, against relapsed and refractory neuroblastoma</p>","year":2019,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"National Cancer Institute","keywords":"Neuroblastoma; Flow cytometry; In vitro; In vivo; Cancer research; Medicine; Cell culture; Cytotoxicity; Cytotoxic T cell; In vitro toxicology; Cancer; Pharmacology; Immunology; Biology; Internal medicine","score_opus":0.018726239825966873,"score_gpt":0.2721011470440515,"score_spread":0.2533749072180846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913788535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477917,0.0025901464,0.000006525129,0.00046849126,0.00009134917,0.0007649943,0.000046373527,0.000030561092,0.0012224094],"genre_scores_gemma":[0.99025387,0.008243359,0.00023753899,0.0002524086,0.00003715351,0.00001911114,0.000015932517,0.00004346548,0.0008971557],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99834484,0.00008561342,0.00026806776,0.0005338678,0.0003405673,0.00042702272],"domain_scores_gemma":[0.99902356,0.00014571176,0.00013730697,0.00033104554,0.00006537289,0.00029697744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020381616,0.00029403012,0.00058416335,0.00025017696,0.00007528457,0.00003260455,0.000069526635,0.00010063619,0.000041589978],"category_scores_gemma":[0.000039022503,0.00022771858,0.00007955065,0.00018920963,0.00017951234,0.00018081724,0.000082486426,0.00025411227,0.000008107231],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041427007,0.0014638675,0.006393843,0.000119218326,0.00012660967,0.00023096755,0.00018711042,0.0000014153976,0.95964134,0.000026033533,0.000115345174,0.027551547],"study_design_scores_gemma":[0.041027114,0.008495127,0.70857227,0.00039573465,0.00006217128,0.00024130655,0.00003875008,0.001867767,0.19021659,0.000052285097,0.048435133,0.00059577136],"about_ca_topic_score_codex":0.000034705066,"about_ca_topic_score_gemma":0.000024842808,"teacher_disagreement_score":0.76942474,"about_ca_system_score_codex":0.000041907733,"about_ca_system_score_gemma":0.00008330269,"threshold_uncertainty_score":0.92860943},"labels":[],"label_agreement":null},{"id":"W2936758797","doi":"10.2147/ott.s191179","title":"<p>Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis</p>","year":2019,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fourth Military Medical University","keywords":"Medicine; Rituximab; Waldenstrom macroglobulinemia; Macroglobulinemia; Meta-analysis; Internal medicine; Oncology; Lymphoma; Multiple myeloma","score_opus":0.0625034392856693,"score_gpt":0.34469866020691664,"score_spread":0.2821952209212473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936758797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076433277,0.9878334,0.000016298653,0.00028201242,0.000045483925,0.010701677,0.00012916717,0.00004940919,0.00017824402],"genre_scores_gemma":[0.00079397927,0.9944236,0.00025999596,0.00095246185,0.000033657423,0.0009605624,0.00095120573,0.0001474114,0.0014770917],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99420047,0.0008719393,0.0016968853,0.0012112875,0.0013183372,0.0007010861],"domain_scores_gemma":[0.9961424,0.0005516218,0.0010126579,0.001491871,0.00048330065,0.0003181363],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015833518,0.0011206778,0.012035602,0.0007295158,0.00011112302,0.00012575705,0.0003595806,0.00051885843,0.00048179866],"category_scores_gemma":[0.000112108675,0.0006146046,0.0014610633,0.0014151237,0.00019843968,0.00012566,0.00007523826,0.0006316661,0.00006301646],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041061782,0.0019444556,0.0000833772,0.85946405,0.10792874,0.00009421361,0.00010713647,0.0000017886305,8.881096e-7,0.00018396688,0.0005102459,0.029270522],"study_design_scores_gemma":[0.052569035,0.0023778845,0.0001081189,0.07437323,0.4864156,0.000113847134,0.000004018521,0.00022490752,0.0000013613754,0.000028339433,0.38226795,0.0015156996],"about_ca_topic_score_codex":0.000068934474,"about_ca_topic_score_gemma":0.00006700913,"teacher_disagreement_score":0.7850908,"about_ca_system_score_codex":0.0024235074,"about_ca_system_score_gemma":0.002644691,"threshold_uncertainty_score":0.9996305},"labels":[],"label_agreement":null},{"id":"W2952542100","doi":"10.2147/ott.s196322","title":"<p>The role of miR-382-5p in glioma cell proliferation, migration and invasion</p>","year":2019,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Nurses in Oncology","funders":"","keywords":"Glioma; Cancer research; Cell growth; Cell migration; Cell; Medicine; Biology; Cell biology; Genetics","score_opus":0.004721691462164456,"score_gpt":0.20947164118004732,"score_spread":0.20474994971788288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952542100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811389,0.017784389,0.000019241683,0.00020545813,0.000043624517,0.0003743612,0.000009821803,0.0000041803164,0.000420067],"genre_scores_gemma":[0.99738485,0.0020379135,0.0001456422,0.000084827145,0.00006819461,0.000019225716,0.00008205498,0.000013895198,0.00016342952],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930423,0.000062227045,0.00018744594,0.00023152858,0.00009680951,0.00011774027],"domain_scores_gemma":[0.99958026,0.0000116003785,0.00009599017,0.00020815276,0.00006412722,0.00003985461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016151465,0.00011507157,0.000119610246,0.000044549888,0.000047123423,0.000023411952,0.0000686073,0.00010261564,0.000030928277],"category_scores_gemma":[0.000009202655,0.00008560268,0.00003369453,0.00007527114,0.000047676574,0.000010198433,0.000029716626,0.00003591691,0.0000028861814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012936509,0.00007303059,0.027801204,0.000015202368,0.000014457302,3.700135e-7,0.0002023277,0.00001725466,0.96828276,0.00021770275,0.00018510985,0.0030611947],"study_design_scores_gemma":[0.0012431375,0.0002745142,0.07321231,0.000017154038,0.000006455134,0.0000060139528,0.000040317274,0.00056250574,0.83334935,0.0006733722,0.09046406,0.00015078396],"about_ca_topic_score_codex":0.000016614325,"about_ca_topic_score_gemma":0.00013420582,"teacher_disagreement_score":0.13493341,"about_ca_system_score_codex":0.0000071141676,"about_ca_system_score_gemma":0.000042182488,"threshold_uncertainty_score":0.34907758},"labels":[],"label_agreement":null},{"id":"W2987649946","doi":"10.2147/ott.s229514","title":"<p>Emerging Roles Of hsa-circ-0046600 Targeting The miR-640/HIF-1α Signalling Pathway In The Progression Of HCC</p>","year":2019,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Henan Provincial People's Hospital","keywords":"Hepatocellular carcinoma; Western blot; Cancer research; microRNA; Molecular biology; Biomarker; Real-time polymerase chain reaction; Chemistry; Biology; Gene; Biochemistry","score_opus":0.007634631463003093,"score_gpt":0.2515867747354772,"score_spread":0.2439521432724741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987649946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9373784,0.06092093,0.00005926555,0.00022456683,0.0001084961,0.00044004005,0.000018895678,0.000007782189,0.00084159675],"genre_scores_gemma":[0.99596095,0.0033618077,0.00020302576,0.0001720897,0.00014787736,0.000029292132,0.0000518305,0.000031882326,0.000041237396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843216,0.00021840913,0.00038791276,0.00035456536,0.00030499,0.00030196994],"domain_scores_gemma":[0.9990904,0.000077605524,0.0002698674,0.00042614923,0.000088758105,0.000047243004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076719,0.00021937481,0.0002845751,0.00004988769,0.00011778634,0.000028464832,0.00040039295,0.00012704972,0.00004648194],"category_scores_gemma":[0.000057919056,0.00013130216,0.0001643336,0.00014760645,0.00014545074,0.000010552121,0.000093299444,0.00012527808,0.0000017622525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015212364,0.00018703537,0.010635321,0.000051310064,0.00007436159,0.0000034293334,0.0007604623,0.00014736781,0.96770746,0.0004690233,0.00013056934,0.019681524],"study_design_scores_gemma":[0.002092492,0.0007287965,0.012265937,0.00027826856,0.000026764861,0.0000105603895,0.0008180638,0.0005193482,0.8359389,0.0006784313,0.14619878,0.0004436649],"about_ca_topic_score_codex":0.0000115350895,"about_ca_topic_score_gemma":0.000022796221,"teacher_disagreement_score":0.14606822,"about_ca_system_score_codex":0.000007120903,"about_ca_system_score_gemma":0.00007139069,"threshold_uncertainty_score":0.53543466},"labels":[],"label_agreement":null},{"id":"W2995767122","doi":"10.2147/ott.s235811","title":"<p>Impact of Fucosylation on Self-Assembly of Prostate and Breast Tumor Spheroids by Using Cyclo-RGDfK(TPP) Peptide and Image Object Detection</p>","year":2019,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Queen's University; Russian Foundation for Basic Research","keywords":"Fucosylation; Prostate; Medicine; Breast tumor; Peptide; Spheroid; Internal medicine; Chemistry; Biochemistry; Glycoprotein; Breast cancer; Cancer","score_opus":0.005540476564820925,"score_gpt":0.25823770620068376,"score_spread":0.25269722963586283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995767122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964527,0.002118346,0.000077171775,0.0000277718,0.00003097279,0.0004734036,0.00007856314,0.0000097643815,0.00073132134],"genre_scores_gemma":[0.99784094,0.0014546275,0.00039814872,0.000022895187,0.000040521238,0.000008026636,0.00003177552,0.00002797647,0.00017508982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893224,0.00008497086,0.00023289914,0.00033620856,0.00018939828,0.00022427346],"domain_scores_gemma":[0.9993716,0.000019951978,0.00015762963,0.00020462414,0.00014360044,0.00010259733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023632213,0.00019682139,0.00025271034,0.00007164437,0.000082671046,0.000036985304,0.000059716567,0.000098857716,0.000028474156],"category_scores_gemma":[0.000014165839,0.00015811043,0.00007094422,0.00010306075,0.00007943417,0.000022037879,0.00004235544,0.000082729675,0.0000015634341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006542545,0.00011151899,0.01366601,0.000045685298,0.00008971501,0.0000011954021,0.00010234177,0.00001755528,0.9763865,0.00001634787,0.00006572071,0.008843163],"study_design_scores_gemma":[0.0036658493,0.003275598,0.11144205,0.000057447738,0.000016298178,0.000076864584,0.00003832913,0.0028819854,0.87340164,0.00009343544,0.0047137365,0.00033676927],"about_ca_topic_score_codex":0.00009318952,"about_ca_topic_score_gemma":0.000034311208,"teacher_disagreement_score":0.10298485,"about_ca_system_score_codex":0.000022210892,"about_ca_system_score_gemma":0.00006933475,"threshold_uncertainty_score":0.6447556},"labels":[],"label_agreement":null},{"id":"W3107430348","doi":"10.2147/ott.s281397","title":"<p>The Immunostimulative Effect and Mechanisms of a Novel Mouse Anti-Human PD-1 Monoclonal Antibody on Jurkat Lymphocytic Cells Cocultured with Hepatoma Cells</p>","year":2020,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kane Biotech (Canada)","funders":"","keywords":"Jurkat cells; Monoclonal antibody; Cancer research; Molecular biology; Cell culture; Antibody; Chemistry; Immunology; Cell biology; Medicine; Biology; T cell; Immune system; Genetics","score_opus":0.012559176557217866,"score_gpt":0.2609022516389771,"score_spread":0.24834307508175926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107430348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928577,0.004505827,0.00038518975,0.0006473548,0.00010848621,0.0010990398,0.000088623434,0.000055744124,0.000252046],"genre_scores_gemma":[0.9946885,0.0029389653,0.0004209629,0.0015242848,0.00009617706,0.000022646169,0.000047499037,0.000061964325,0.0001989619],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983068,0.00009811781,0.00035956,0.0004987024,0.0003997684,0.00033705184],"domain_scores_gemma":[0.99902713,0.00016068073,0.00023337925,0.00030851387,0.0000965223,0.00017377503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025382865,0.00044234982,0.0007487608,0.00007052728,0.000259075,0.000053796135,0.00014527363,0.00014850797,0.00007204935],"category_scores_gemma":[0.0000070772207,0.00025000953,0.00016089469,0.00024011696,0.000315128,0.00008378183,0.00003819512,0.00018615832,0.000003423039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010449513,0.00028206376,0.000417493,0.00010019502,0.00069549837,0.000034232653,0.0016017946,0.000027062038,0.98397493,0.00045826496,0.00020307442,0.0017558696],"study_design_scores_gemma":[0.027321517,0.012186404,0.008947911,0.0002735124,0.00017158246,0.000052630523,0.00010431422,0.0026247439,0.93920094,0.000048695376,0.008597613,0.00047013795],"about_ca_topic_score_codex":0.00008961707,"about_ca_topic_score_gemma":0.000009878243,"teacher_disagreement_score":0.044774,"about_ca_system_score_codex":0.00008321062,"about_ca_system_score_gemma":0.00011712801,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W3115177595","doi":"10.2147/ott.s273803","title":"The Roles of Integrin α5β1 in Human Cancer","year":2020,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Agriculture","funders":"Fundamental Research Funds for the Central Universities; Natural Science Foundation of Chongqing; National Natural Science Foundation of China","keywords":"Integrin; Fibronectin; Extracellular matrix; Cell adhesion; Cell biology; Metastasis; Cancer research; Angiogenesis; Cancer cell; Carcinogenesis; Cell; Biology; Motility; Collagen receptor; Mediator; Cell migration; Tumor progression; Cancer; Biochemistry; Genetics","score_opus":0.06734611580005802,"score_gpt":0.42024098109027386,"score_spread":0.35289486529021585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115177595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005240772,0.99686646,6.602247e-7,0.00043597945,0.00004399583,0.00068117684,0.000011249015,0.00000858977,0.0014278365],"genre_scores_gemma":[0.00013376592,0.9985041,0.00001895326,0.00006956502,0.0001268146,0.000095461015,0.000016571006,0.00004111842,0.0009936616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998722,0.00013555973,0.00041227505,0.0002613885,0.00025857936,0.00021019361],"domain_scores_gemma":[0.9993093,0.000145652,0.00013783555,0.00025514865,0.000047793466,0.00010425048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024712583,0.00021990044,0.0011170635,0.00010141641,0.00005947953,0.000018765884,0.00018095759,0.00014051337,0.00019034377],"category_scores_gemma":[0.000028769746,0.000111303125,0.00021287701,0.00022053787,0.00012605217,0.000011829411,0.00007082735,0.0005644788,0.0000063448483],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004199979,0.00005031129,0.000102300735,0.0015827627,0.00011256136,0.000037537553,0.00012580468,2.1384256e-8,0.00013451117,0.00016377491,0.00043951793,0.9972089],"study_design_scores_gemma":[0.0005046264,0.00023331678,0.000087057175,0.0035166983,0.000039319755,0.000007664192,0.000030127994,0.0000030091728,0.00006690789,0.00006420865,0.9953482,0.000098876866],"about_ca_topic_score_codex":0.00014300841,"about_ca_topic_score_gemma":0.00024433306,"teacher_disagreement_score":0.99711,"about_ca_system_score_codex":0.00006639776,"about_ca_system_score_gemma":0.00029071467,"threshold_uncertainty_score":0.45388097},"labels":[],"label_agreement":null},{"id":"W3120637385","doi":"10.2147/ott.s276912","title":"Case Report: Myeloid Sarcoma Development During Treatment for B Cell Lymphoblastic Lymphoma in a Boy with KRAS/NRAS Gene Mutations","year":2021,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; Myeloid sarcoma; Medicine; Lymphoma; Lymphoblastic lymphoma; Hematopoietic stem cell transplantation; Myeloid; Chemotherapy; Oncology; Cancer; Pathology; Internal medicine; Disease; Immunology; T cell","score_opus":0.02390182928471024,"score_gpt":0.2837764498929889,"score_spread":0.25987462060827865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120637385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99490416,0.0030574333,0.0003019247,0.00049073517,0.00004376173,0.00081449107,0.000015799547,0.000035945348,0.0003357628],"genre_scores_gemma":[0.9763392,0.0010746852,0.018656079,0.0001399012,0.000100875906,0.00037515096,0.00014567914,0.000056937348,0.0031114416],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984687,0.000039935097,0.0003519303,0.0004908243,0.00021375505,0.00043484804],"domain_scores_gemma":[0.99913675,0.00009761035,0.0000859318,0.0002994033,0.00016015809,0.0002201541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014545677,0.00024710497,0.00038786416,0.00015250947,0.00022750352,0.000040567666,0.000040352716,0.00008079652,0.000051910793],"category_scores_gemma":[0.000027700238,0.00018124215,0.00006254262,0.00024494066,0.00004956984,0.0000635846,0.000027748643,0.00006336349,0.0000056517583],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004765766,0.004025475,0.05943384,0.0003727435,0.00093148707,0.6354534,0.010010044,0.00008243182,0.1501283,0.000037635305,0.00013089165,0.13462798],"study_design_scores_gemma":[0.064872965,0.002522137,0.10402258,0.00019976533,0.000119588796,0.1989418,0.0020745161,0.00088650594,0.58725333,0.00009877149,0.038256276,0.00075178465],"about_ca_topic_score_codex":0.00018768497,"about_ca_topic_score_gemma":0.00028145453,"teacher_disagreement_score":0.437125,"about_ca_system_score_codex":0.00088787416,"about_ca_system_score_gemma":0.0015623731,"threshold_uncertainty_score":0.73908406},"labels":[],"label_agreement":null},{"id":"W3120829320","doi":"10.2147/ott.s242248","title":"Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets","year":2021,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Medicine; Bladder cancer; Metastasis; Pathological; Angiogenesis; Cancer; Oncology; Disease; Tumor progression; Urokinase receptor; Plasminogen activator; Internal medicine; Cancer research","score_opus":0.06068501049646511,"score_gpt":0.37684074340441415,"score_spread":0.316155732907949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120829320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011579647,0.98708516,0.00011172973,0.000037365317,0.00028739043,0.0007490904,0.00010156225,0.000007470762,0.000040585866],"genre_scores_gemma":[0.018925576,0.9801157,0.00014443588,0.00012789221,0.00033172843,0.00010808158,0.0000927906,0.00007127398,0.0000824939],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978783,0.00034513854,0.00061637006,0.00065799267,0.00020050745,0.00030168766],"domain_scores_gemma":[0.9990965,0.00004452535,0.00038511358,0.00030528056,0.00004206231,0.0001265118],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030555585,0.00044048752,0.0011465636,0.00008092545,0.00008041649,0.000035615372,0.0001457822,0.0005888689,0.00009925849],"category_scores_gemma":[0.000024515224,0.000301001,0.00033984074,0.00007546865,0.00013165604,0.000011300469,0.00014973557,0.00028368813,5.3138245e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042217778,0.0006317903,0.0014174671,0.0012678334,0.0013120472,0.000045791003,0.00015843309,6.290027e-7,0.035063893,0.00022267966,0.0004063663,0.9590509],"study_design_scores_gemma":[0.004105332,0.0011077571,0.00015376844,0.007519255,0.00028348342,0.000035302146,0.00013963938,0.000010376649,0.025963256,0.000718263,0.9588637,0.0010998622],"about_ca_topic_score_codex":0.000017547876,"about_ca_topic_score_gemma":0.000005015639,"teacher_disagreement_score":0.95845735,"about_ca_system_score_codex":0.000027107588,"about_ca_system_score_gemma":0.0002986117,"threshold_uncertainty_score":0.9999442},"labels":[],"label_agreement":null},{"id":"W3127330586","doi":"10.2147/ott.s291086","title":"Combination Therapy with iRGD-antiCD3 and PD-1 Blockade Enhances Antitumor Potency of Cord Blood-Derived T Cells","year":2021,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"Government of Jiangsu Province; Natural Science Foundation of Jiangsu Province; National Natural Science Foundation of China","keywords":"In vivo; Cancer research; Immune system; Tumor microenvironment; T cell; Immunotherapy; In vitro; Cytotoxic T cell; CD3; Antibody; Chemistry; Antigen; CD8; Medicine; Immunology; Biology; Biochemistry","score_opus":0.019489528036816608,"score_gpt":0.28453166111524125,"score_spread":0.26504213307842467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127330586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752061,0.021266457,0.00001965032,0.0016908157,0.000068771296,0.00026864803,0.000015666057,0.000016485465,0.0014474055],"genre_scores_gemma":[0.8900688,0.10635183,0.0009985373,0.0003083777,0.000080458696,0.00000787849,0.000023342593,0.000018150762,0.002142624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988572,0.00006138506,0.00021754586,0.00029780768,0.00032318983,0.00024284203],"domain_scores_gemma":[0.9992999,0.00008659684,0.00008881168,0.00016243737,0.00022755518,0.00013468953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001322439,0.00018133412,0.00041082455,0.000066298955,0.00012760243,0.000029941924,0.00005673238,0.00006257454,0.0002515994],"category_scores_gemma":[0.000008398728,0.000117219875,0.000057520232,0.00015490632,0.00024837157,0.00007023456,0.00002789155,0.00015403383,0.0000026244697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016407992,0.00074234296,0.033842094,0.00010338102,0.0002797717,0.00017460724,0.00038984226,2.4529126e-7,0.9284567,0.0005552442,0.000056757304,0.033758186],"study_design_scores_gemma":[0.004637168,0.0030000496,0.106276385,0.00012664295,0.000034685618,0.00016189499,0.00011799904,0.0000511524,0.872121,0.0004080439,0.012885843,0.00017914649],"about_ca_topic_score_codex":0.00024274016,"about_ca_topic_score_gemma":0.000021812913,"teacher_disagreement_score":0.0851373,"about_ca_system_score_codex":0.000004912553,"about_ca_system_score_gemma":0.00011361939,"threshold_uncertainty_score":0.47800878},"labels":[],"label_agreement":null},{"id":"W3159335234","doi":"10.2147/ott.s291801","title":"A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies","year":2021,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Merck Sharp and Dohme; EMD Serono; Genentech; Plexxikon; Bausch Health; STCube; PharmaMar; European Society for Medical Oncology; Astellas Pharma; Silverback Therapeutics; Daiichi Sankyo Europe; National Cancer Institute; Calithera Biosciences; Aminex Therapeutics; Agios Pharmaceuticals; IFM Therapeutics; Symphogen; Pfizer; Incyte; Boston Pharmaceuticals; Five Prime Therapeutics; Loxo Oncology; Astex Pharmaceuticals; Eli Lilly and Company; National Comprehensive Cancer Network; Principia Biopharma; University of Texas MD Anderson Cancer Center; Puma Biotechnology; National Institutes of Health; BioMarin Pharmaceutical; Regeneron Pharmaceuticals; Baxalta; Immune Deficiency Foundation; Helsinn; Exelixis; Karyopharm Therapeutics; Bristol-Myers Squibb; American Society of Clinical Oncology; Sanofi; Amgen","keywords":"Crizotinib; Pazopanib; Medicine; ROS1; Internal medicine; Oncology; Tyrosine-kinase inhibitor; Progressive disease; Gastroenterology; Pharmacology; Cancer; Sunitinib; Chemotherapy; Lung cancer; Adenocarcinoma","score_opus":0.00900558308648964,"score_gpt":0.2918006701008566,"score_spread":0.28279508701436695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159335234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955321,0.0010945733,0.000006831224,0.0014314721,0.00020881419,0.0013077601,0.000044568576,0.00001365049,0.0003602168],"genre_scores_gemma":[0.9984314,0.00022603993,0.0002418166,0.0005053365,0.000093436196,0.00012758172,0.000040424085,0.000026117503,0.0003078609],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989591,0.00006969245,0.00023247169,0.00024029397,0.00029914075,0.00019928986],"domain_scores_gemma":[0.9992362,0.0000582908,0.00014841814,0.00029477506,0.00020054239,0.000061756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008414033,0.00018359866,0.0003592825,0.00003418144,0.00013519885,0.000023614977,0.000060535756,0.000041269366,0.000031366097],"category_scores_gemma":[0.000017609087,0.000077974655,0.000064462336,0.00026557283,0.00014267697,0.00008182211,0.000022029488,0.00012302161,5.8265425e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5137051,0.04015978,0.21216844,0.00029864183,0.0031228478,0.00019832062,0.02345299,0.000059114376,0.045986637,0.0018653955,0.0019367383,0.15704605],"study_design_scores_gemma":[0.7699222,0.041535877,0.09554537,0.0007438713,0.00042052983,0.000012866726,0.0019785566,0.000017035762,0.06427233,0.0001806953,0.024957731,0.00041295087],"about_ca_topic_score_codex":0.000028069506,"about_ca_topic_score_gemma":0.00007838228,"teacher_disagreement_score":0.25621715,"about_ca_system_score_codex":0.000043632528,"about_ca_system_score_gemma":0.00028519408,"threshold_uncertainty_score":0.3179714},"labels":[],"label_agreement":null},{"id":"W3190167812","doi":"10.2147/ott.s297336","title":"Long Non-Coding RNA TRG-AS1 Promoted Proliferation and Invasion of Lung Cancer Cells Through the miR-224-5p/SMAD4 Axis","year":2021,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Gene knockdown; Downregulation and upregulation; Cell growth; Cancer research; Lung cancer; Western blot; Long non-coding RNA; Competing endogenous RNA; Biology; microRNA; RNA; Cell culture; Gentamicin protection assay; Molecular biology; Medicine; Pathology; Gene; Biochemistry","score_opus":0.013700575000453364,"score_gpt":0.2897370582226619,"score_spread":0.27603648322220853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190167812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597421,0.028216375,0.009815674,0.0008651069,0.00019338829,0.0006918651,0.000026575262,0.000008409078,0.00044048685],"genre_scores_gemma":[0.969241,0.029380247,0.0004168075,0.00031170994,0.0001480615,0.00006356008,0.0000654399,0.000030438316,0.00034272415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988908,0.00010449312,0.00019474943,0.0003840717,0.00019010472,0.00023573496],"domain_scores_gemma":[0.9993937,0.0000152216235,0.00008781402,0.0002784013,0.00016470464,0.000060177583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019593647,0.00016041931,0.00018151035,0.000024119725,0.00016745621,0.000051283227,0.00010004306,0.00015829933,0.000058156686],"category_scores_gemma":[0.000020345851,0.00011879266,0.00006226178,0.00012456405,0.00008300215,0.000011214932,0.000100691235,0.00014870043,4.5789128e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015073192,0.000057708687,0.00018146036,0.00005398364,0.0001494335,0.000007755332,0.00048042162,0.0000334404,0.9874867,0.00004544822,0.000378096,0.010974826],"study_design_scores_gemma":[0.0010952832,0.00023576406,0.00043452895,0.000062354455,0.00001809056,0.000012359533,0.00006291631,0.0008630609,0.98993164,0.00009917471,0.007039076,0.00014576128],"about_ca_topic_score_codex":0.00014873642,"about_ca_topic_score_gemma":0.00016099637,"teacher_disagreement_score":0.010829065,"about_ca_system_score_codex":0.000020382922,"about_ca_system_score_gemma":0.0001780919,"threshold_uncertainty_score":0.48442242},"labels":[],"label_agreement":null},{"id":"W4226296095","doi":"10.2147/ott.s346725","title":"Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib","year":2022,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Afatinib; PTEN; Cancer research; Medicine; Epidermal growth factor receptor; Temozolomide; Cancer; Gefitinib; Oncology; Mutation; Internal medicine; Glioma; Biology; Gene; PI3K/AKT/mTOR pathway; Signal transduction; Genetics","score_opus":0.007874613956298807,"score_gpt":0.24204197147624149,"score_spread":0.23416735751994266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226296095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983254,0.00067130104,0.0000068975796,0.0002880597,0.000019964185,0.00045037508,0.00018792214,0.000014712656,0.00003535683],"genre_scores_gemma":[0.9990371,0.000049357364,0.00032627463,0.00031452943,0.00001382304,0.00009339385,0.00010740179,0.000023202823,0.000034945315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990135,0.00006998365,0.00017162561,0.00028714337,0.000299786,0.00015795771],"domain_scores_gemma":[0.9993437,0.00007929926,0.00010705989,0.00027172477,0.00006215065,0.00013606877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009297866,0.0001544131,0.0004304513,0.00028754302,0.00010664503,0.000011592487,0.000057629168,0.000016550395,0.0005841362],"category_scores_gemma":[0.0000039835268,0.00009731873,0.000071511604,0.0005123618,0.00003536083,0.00002394422,0.000033533837,0.000062717874,0.0000019308654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022519052,0.0011017501,0.9649266,0.0000029708597,0.0021145353,0.000129249,0.0010026849,0.0001228347,0.0032749586,0.0000040808327,0.000031977426,0.004769295],"study_design_scores_gemma":[0.006124038,0.008179038,0.9822097,0.00002319142,0.0005046811,0.0000035345447,0.00008178324,0.000021108812,0.0020342262,0.0000029702787,0.00069726736,0.000118456184],"about_ca_topic_score_codex":0.00016641292,"about_ca_topic_score_gemma":0.00010390963,"teacher_disagreement_score":0.017283093,"about_ca_system_score_codex":0.00006488726,"about_ca_system_score_gemma":0.000049704016,"threshold_uncertainty_score":0.6395882},"labels":[],"label_agreement":null},{"id":"W4307636191","doi":"10.2147/ott.s370244","title":"Ketoacidosis in a Patient with Type 2 Diabetes Requiring Alpelisib: Learnings and Observations Regarding Alpelisib Initiation and Rechallenge","year":2022,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Cancer Care Ontario; University of Toronto","funders":"","keywords":"Medicine; Diabetic ketoacidosis; Ketoacidosis; Type 2 diabetes; Type 1 diabetes; Diabetes mellitus; Endocrinology","score_opus":0.03314721665539851,"score_gpt":0.24566408464348818,"score_spread":0.21251686798808966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307636191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868082,0.009838304,0.0000029857663,0.0015131638,0.000046672285,0.0003878639,0.000002732888,0.000032759173,0.0013673452],"genre_scores_gemma":[0.9907711,0.007593297,0.0006221587,0.0006882419,0.000022327384,0.00008839754,0.000037297457,0.000020527601,0.00015665573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992451,0.00004701138,0.00013977432,0.00024663855,0.00014725862,0.000174185],"domain_scores_gemma":[0.99969023,0.000051042054,0.000067336485,0.00010078285,0.000032534655,0.000058065787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019390183,0.00012318227,0.00020362576,0.00012509215,0.00017991744,0.000033718086,0.000021802567,0.0000251258,0.00003444715],"category_scores_gemma":[0.000015432814,0.000098524484,0.000015139621,0.00016265808,0.00003148546,0.00014863507,0.000063510415,0.00012168099,3.8363342e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044372925,0.00030959418,0.7842428,0.000084109335,0.00026766342,0.000058037735,0.0063922554,0.00003219466,0.002398964,0.0008266884,0.00034671865,0.20459726],"study_design_scores_gemma":[0.012345624,0.0103474045,0.7709318,0.00041228684,0.00020927262,0.000025050644,0.0054101176,0.0017526044,0.0009903264,0.0013729375,0.19554971,0.00065287226],"about_ca_topic_score_codex":0.00002876837,"about_ca_topic_score_gemma":0.000015839605,"teacher_disagreement_score":0.20394439,"about_ca_system_score_codex":0.000048845137,"about_ca_system_score_gemma":0.000015080314,"threshold_uncertainty_score":0.4017712},"labels":[],"label_agreement":null},{"id":"W4309614828","doi":"10.2147/ott.s366625","title":"CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemia and Lymphoma: Current Insights","year":2022,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Memorial University of Newfoundland","funders":"","keywords":"CD24; Cancer research; Lymphoma; Biomarker; Leukemia; Medicine; Immunology; Immune system; Biology; Cancer; Internal medicine; Cancer stem cell","score_opus":0.013971225102938576,"score_gpt":0.24779340506140374,"score_spread":0.23382217995846516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309614828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006689855,0.9891921,0.0000049578325,0.0000052351525,0.0025577582,0.00071542355,0.000011671007,0.000032683176,0.0007903034],"genre_scores_gemma":[0.002663162,0.9946891,0.0000062571617,0.000116364055,0.000037918267,0.00011362354,0.0007641574,0.000056756173,0.0015526335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982568,0.00038871774,0.00043064027,0.0005351192,0.00007218633,0.0003165341],"domain_scores_gemma":[0.9993297,0.000072787654,0.00029718888,0.00023604595,0.000032473406,0.000031817886],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011245997,0.00048051862,0.00095188804,0.00027075075,0.0002672225,0.00004179765,0.0001418104,0.000279596,0.0016871715],"category_scores_gemma":[0.000003781203,0.00032598674,0.0001492758,0.00015886188,0.00010852053,0.00012656237,0.00007800763,0.0005791282,0.00008074504],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004500555,0.0005420905,0.000108854925,0.00037424444,0.00022940636,0.0000052003534,0.00024352866,3.3969386e-7,0.0000149206335,0.00004612654,0.00041450196,0.99757075],"study_design_scores_gemma":[0.0045165326,0.00091985415,0.00029959748,0.0003617942,0.00010409541,0.0000323824,0.000042296408,0.0000012630165,0.000017515029,0.000041903506,0.9932641,0.0003986644],"about_ca_topic_score_codex":0.000077327255,"about_ca_topic_score_gemma":0.0000033242582,"teacher_disagreement_score":0.99717206,"about_ca_system_score_codex":0.00020016619,"about_ca_system_score_gemma":0.0002306764,"threshold_uncertainty_score":0.99991924},"labels":[],"label_agreement":null},{"id":"W4393090889","doi":"10.2147/ott.s442504","title":"Progerin Inhibits the Proliferation and Migration of Melanoma Cells by Regulating the Expression of Paxillin","year":2024,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"National Natural Science Foundation of China","keywords":"Paxillin; Cell biology; Cancer research; Melanoma; Expression (computer science); Focal adhesion; Chemistry; Biology; Computer science; Phosphorylation","score_opus":0.0049351374831575244,"score_gpt":0.21349894587682838,"score_spread":0.20856380839367086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898154,0.009422587,0.00016369992,0.00030196298,0.000061177656,0.0001581313,0.0000065911686,0.0000033680365,0.00006709286],"genre_scores_gemma":[0.997742,0.0018773266,0.000120761055,0.000054028013,0.000080493926,0.0000064714277,0.000019637817,0.0000071768595,0.00009213115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99965805,0.000033661923,0.000101754056,0.000106705316,0.000053857824,0.00004598353],"domain_scores_gemma":[0.9998301,0.000009671536,0.00004465442,0.00008320723,0.000022425207,0.000009924285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112868416,0.000056431763,0.00005410706,0.000008316701,0.00005654208,0.000019133584,0.000026020998,0.00004938788,0.0000045436145],"category_scores_gemma":[0.000003352661,0.000027723236,0.000019838899,0.000029517347,0.000049137976,0.000004911797,0.00001382875,0.00003555494,1.0296479e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053849537,0.0000071086642,0.00066147884,0.00001565249,0.000012247655,4.7485432e-8,0.0003614858,0.0000029647788,0.97314715,0.00010342802,0.0007982296,0.024836347],"study_design_scores_gemma":[0.00012976567,0.00022296673,0.0009532398,0.000019260564,0.0000043730047,0.000002884058,0.00006548283,0.000266829,0.956315,0.00017699502,0.041807078,0.00003613491],"about_ca_topic_score_codex":0.000011191961,"about_ca_topic_score_gemma":0.000006758362,"teacher_disagreement_score":0.04100885,"about_ca_system_score_codex":0.0000011747215,"about_ca_system_score_gemma":0.000008976415,"threshold_uncertainty_score":0.11305208},"labels":[],"label_agreement":null},{"id":"W4393120052","doi":"10.2147/ott.s444536","title":"Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study","year":2024,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Receiver operating characteristic; Cohort; Retrospective cohort study; Hepatocellular carcinoma; Internal medicine; Concordance; Cirrhosis; Framingham Risk Score","score_opus":0.021777842447134134,"score_gpt":0.23255064357896907,"score_spread":0.21077280113183494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393120052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462515,0.0027303873,0.00037175542,0.000036031386,0.000025179123,0.002107289,0.00004010567,0.00005040482,0.000013681687],"genre_scores_gemma":[0.9980598,0.00015315927,0.001301785,0.00000870691,0.000009978051,0.00022590099,0.0001706805,0.000042195858,0.000027765456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988156,0.00007093182,0.00032300735,0.0003807515,0.00022930696,0.0001804235],"domain_scores_gemma":[0.9995589,0.000052567008,0.00010858781,0.00010550766,0.00009846131,0.00007593073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003457164,0.00021080897,0.00038347172,0.00019320573,0.000106760235,0.000028711342,0.000026231395,0.00007394749,0.000009709912],"category_scores_gemma":[0.000017875982,0.00015441109,0.000050752995,0.00019996271,0.000033253287,0.0000773355,0.000012037196,0.00016847419,3.064124e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065586914,0.00067055284,0.9875244,0.00009713355,0.00032359536,0.000021142572,0.0067380774,0.000050586914,0.00008844025,0.000008258838,8.523469e-7,0.0038211055],"study_design_scores_gemma":[0.007864175,0.0029389465,0.6292031,0.00014192697,0.00014364206,7.469981e-7,0.000076207616,0.35733718,0.002082633,0.000035144825,0.00004668824,0.00012965898],"about_ca_topic_score_codex":0.00038023046,"about_ca_topic_score_gemma":0.00008776856,"teacher_disagreement_score":0.35832134,"about_ca_system_score_codex":0.000089099995,"about_ca_system_score_gemma":0.00010978212,"threshold_uncertainty_score":0.62967014},"labels":[],"label_agreement":null},{"id":"W4406802705","doi":"10.2147/ott.s496228","title":"Dynamic Coupling of MAPK Signaling to the Guanine Nucleotide Exchange Factor GEF-H1","year":2025,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Guanine nucleotide exchange factor; Guanine; MAPK/ERK pathway; Cell biology; Coupling (piping); Nucleotide; Factor (programming language); Chemistry; Signal transduction; Computational biology; Bioinformatics; Biology; Medicine; Computer science; Biochemistry; Materials science; Gene","score_opus":0.02186933261750735,"score_gpt":0.30884432124341465,"score_spread":0.2869749886259073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406802705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002681607,0.9950185,0.0009188785,0.00007644579,0.00016965864,0.0008812458,0.0001528924,0.00001283317,0.0000879835],"genre_scores_gemma":[0.0022719628,0.9959078,0.00045093294,0.00018517686,0.000185052,0.0000766686,0.00020774423,0.00004529638,0.00066937844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869627,0.000056391953,0.00042582696,0.0004306181,0.00014699773,0.00024388585],"domain_scores_gemma":[0.9991411,0.000045963727,0.00024608144,0.00040337103,0.00008074967,0.000082765364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000269418,0.0003533963,0.00072891155,0.000103903774,0.00013444864,0.00003539848,0.00026431648,0.00023698888,0.00008383796],"category_scores_gemma":[0.000035229485,0.00023287653,0.00029664373,0.00017286747,0.00004832096,0.000002902965,0.0001284559,0.00015033329,0.0000042281654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046265857,0.000049418373,0.0000051624193,0.0032677373,0.00029612894,0.000003783356,0.000077880715,0.000059558686,0.014846994,0.000068937334,0.0002806322,0.9809975],"study_design_scores_gemma":[0.0002554118,0.00014764149,0.0000063822763,0.0023756588,0.00006642457,0.0000040504246,0.000011726661,0.00007193373,0.0026756255,0.000021138358,0.99409133,0.00027267987],"about_ca_topic_score_codex":0.000015523932,"about_ca_topic_score_gemma":0.000012789036,"teacher_disagreement_score":0.9938107,"about_ca_system_score_codex":0.000019089553,"about_ca_system_score_gemma":0.0001454177,"threshold_uncertainty_score":0.9496429},"labels":[],"label_agreement":null},{"id":"W4414003234","doi":"10.2147/ott.s398118","title":"The Role of CELMoD Agents in Multiple Myeloma","year":2025,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Janssen Pharmaceuticals; Kite Pharma; Genentech; Servier; Regeneron Pharmaceuticals; Adaptive Biotechnologies; Karyopharm Therapeutics; BeiGene; Sanofi; Celgene; Bristol-Myers Squibb; AstraZeneca; TG Therapeutics; Amgen; Pfizer","keywords":"Multiple myeloma; Medicine; Computer science; Computational biology; Internal medicine; Biology","score_opus":0.0251265564514516,"score_gpt":0.32038975439380807,"score_spread":0.29526319794235645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414003234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732622,0.015810732,0.0000040733826,0.0005854549,0.000046650173,0.00039741493,0.0000060254324,0.000009709364,0.009877778],"genre_scores_gemma":[0.9917832,0.006845953,0.00013159943,0.00010048449,0.000017005861,0.000034297987,0.000007195172,0.0000070018314,0.001073247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993204,0.00003860145,0.0001572371,0.00014012275,0.00013762325,0.00020603267],"domain_scores_gemma":[0.9995481,0.00013349883,0.00002934942,0.00018652598,0.000040488812,0.0000620801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013595917,0.00008850624,0.00017843874,0.000075101874,0.00009479061,0.000012192795,0.000063788335,0.000041279673,0.000029290462],"category_scores_gemma":[0.000043096465,0.000050516748,0.000047022913,0.00013467229,0.00007993603,0.000025990377,0.000027757307,0.00008939145,0.000003905053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074468885,0.00023181201,0.59820384,0.000011323859,0.000103746264,0.000013829975,0.00013210303,4.07316e-7,0.0048349686,0.000563455,0.00009421381,0.3950656],"study_design_scores_gemma":[0.005297759,0.00023079314,0.8690926,0.000055591852,0.0000060004068,0.000002292511,0.00015217619,0.0012435128,0.01667019,0.0016610639,0.105540186,0.000047859055],"about_ca_topic_score_codex":0.0002993433,"about_ca_topic_score_gemma":0.00010697696,"teacher_disagreement_score":0.39501774,"about_ca_system_score_codex":0.000026303538,"about_ca_system_score_gemma":0.000061201084,"threshold_uncertainty_score":0.20600131},"labels":[],"label_agreement":null},{"id":"W4415506104","doi":"10.2147/ott.s537253","title":"Evaluating the Prognostic Value of a Pan-Cancer Circulating Tumor DNA Next-Generation Sequencing Panel in Advanced Cancer Patients","year":2025,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"Incheon St. Mary's Hospital, Catholic University of Korea","keywords":"Circulating tumor DNA; Circulating tumor cell; Liquid biopsy; Disease; Value (mathematics); DNA sequencing; Biomarker; Predictive value","score_opus":0.06350176517418692,"score_gpt":0.33498611451710997,"score_spread":0.27148434934292304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415506104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98228335,0.016648883,0.00007016495,0.00014338711,0.0002694973,0.00045889255,0.000025627685,0.0000036556241,0.00009653086],"genre_scores_gemma":[0.9931046,0.005568257,0.00030049324,0.0006267062,0.00013935026,0.00018005366,0.000033471235,0.000015042155,0.000032078315],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990892,0.00006411712,0.0002750717,0.00027982838,0.000106477004,0.00018532886],"domain_scores_gemma":[0.9994953,0.00005754501,0.0001449435,0.0001605273,0.00011743372,0.00002425152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021988712,0.00013556448,0.00016350544,0.000036003403,0.000106148334,0.0000305371,0.000096162774,0.000053606593,0.000007864723],"category_scores_gemma":[0.00013116101,0.00010452667,0.000045508525,0.00011989439,0.000046391473,0.000007456776,0.000049415055,0.00007324671,1.3556699e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080866186,0.000054485765,0.11428087,0.000026722506,0.000044715052,4.942007e-7,0.00027439726,0.004259368,0.7744396,0.00013328884,0.000026078498,0.106379114],"study_design_scores_gemma":[0.0077219442,0.0017208547,0.48561856,0.0006746905,0.00010735593,0.0000025546317,0.00053001486,0.06953899,0.4272247,0.0015445192,0.004503134,0.0008127093],"about_ca_topic_score_codex":0.00058615505,"about_ca_topic_score_gemma":0.00035969267,"teacher_disagreement_score":0.37133768,"about_ca_system_score_codex":0.00005718757,"about_ca_system_score_gemma":0.00028222956,"threshold_uncertainty_score":0.4262474},"labels":[],"label_agreement":null}]}